Inhibition	O
of	O
Th1	O
development	O
mediated	O
by	O
GATA-3	B-protein
through	O
an	O
IL-4-independent	O
mechanism	O
.	O

Recently	O
,	O
the	O
transcription	B-protein
factor	I-protein
GATA-3	B-protein
was	O
shown	O
to	O
be	O
selectively	O
expressed	O
in	O
Th2	O
but	O
not	O
Th1	B-cell_type
cells	I-cell_type
and	O
to	O
augment	O
Th2-specific	B-protein
cytokines	I-protein
.	O

Here	O
,	O
we	O
show	O
that	O
loss	O
of	O
GATA-3	B-protein
expression	O
by	O
developing	O
Th1	B-cell_type
cells	I-cell_type
requires	O
IL-12	B-protein
signaling	O
through	O
Stat4	B-protein
and	O
does	O
not	O
simply	O
result	O
from	O
an	O
absence	O
of	O
IL-4	B-protein
.	O

Moreover	O
,	O
we	O
demonstrate	O
a	O
novel	O
role	O
for	O
GATA-3	B-protein
in	O
directly	O
repressing	O
Th1	O
development	O
distinct	O
from	O
its	O
positive	O
actions	O
on	O
Th2-specific	B-protein
cytokines	I-protein
.	O

GATA-3	B-protein
inhibits	O
Th1	B-protein
cytokines	I-protein
by	O
a	O
cell-intrinsic	O
mechanism	O
that	O
is	O
not	O
dependent	O
on	O
IL-4	B-protein
and	O
that	O
may	O
involve	O
repression	O
of	O
IL-12	B-protein
signaling	O
.	O

Thus	O
,	O
GATA-3	B-protein
expression	O
and	O
IL-12	B-protein
signaling	O
are	O
mutually	O
antagonistic	O
,	O
which	O
facilitates	O
rapid	O
dominance	O
of	O
one	O
pathway	O
during	O
early	O
Th	O
development	O
,	O
producing	O
a	O
stable	O
divergence	O
in	O
cytokine	B-protein
profiles	O
.	O

Immunity	NULL
,	NULL
Vol	NULL
.	NULL

9	NULL
,	NULL
745-755	NULL
,	NULL
November	NULL
,	NULL
1998	NULL
,	NULL
Copyright	NULL
©1998	NULL
by	NULL
Cell	NULL
Press	NULL
Inhibition	NULL
of	NULL
Th1i	NULL
Development	NULL
Mediated	NULL
by	NULL
GATA-3	NULL
through	NULL
an	NULL
IL-4-Independent	NULL
Mechanism	NULL
Wenjun	NULL
Ouyang	NULL
,	NULL
*	NULL
Sheila	NULL
H.	NULL
Ranganath	NULL
,	NULL
*	NULL
Kathryn	NULL
Weindel	NULL
,	NULL
*	NULL
Deepta	NULL
Bhattacharya	NULL
,	NULL
t	NULL
Theresa	NULL
L.	NULL
Murphy	NULL
,	NULL
*	NULL
William	NULL
C.	NULL
Sha	NULL
,	NULL
t	NULL
and	NULL
Kenneth	NULL
M.	NULL
Murphy**	NULL
*Department	NULL
of	NULL
Pathology	NULL
and	NULL
Center	NULL
for	NULL
Immunology	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
tMolecular	NULL
and	NULL
Cell	NULL
Biology	NULL
Department	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Berkeley	NULL
Berkeley	NULL
,	NULL
California	NULL
94720-3200	NULL
Summary	NULL
Recently	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
selectively	NULL
expressed	NULL
in	NULL
Th2	NULL
but	NULL
not	NULL
Thi	NULL
cells	NULL
and	NULL
to	NULL
augment	NULL
Th2-specific	NULL
cytokines	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
loss	NULL
of	NULL
GATA-3	NULL
expression	NULL
by	NULL
developing	NULL
Th1	NULL
cells	NULL
requires	NULL
IL-12	NULL
signaling	NULL
through	NULL
Stat4	NULL
and	NULL
does	NULL
not	NULL
simply	NULL
result	NULL
from	NULL
an	NULL
absence	NULL
of	NULL
IL-4	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
demonstrate	NULL
a	NULL
novel	NULL
role	NULL
for	NULL
GATA-3	NULL
in	NULL
directly	NULL
repressing	NULL
Thi	NULL
development	NULL
distinct	NULL
from	NULL
its	NULL
positive	NULL
actions	NULL
on	NULL
Th2-specific	NULL
cytokines	NULL
.	NULL

GATA-3	NULL
inhibits	NULL
Th1	NULL
cytokines	NULL
by	NULL
a	NULL
cell-intrinsic	NULL
mechanism	NULL
that	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
IL-4	NULL
and	NULL
that	NULL
may	NULL
involve	NULL
repression	NULL
of	NULL
IL-12	NULL
signaling	NULL
.	NULL

Thus	NULL
,	NULL
GATA-3	NULL
expression	NULL
and	NULL
IL-12	NULL
signaling	NULL
are	NULL
mutually	NULL
antagonistic	NULL
,	NULL
which	NULL
facilitates	NULL
rapid	NULL
dominance	NULL
of	NULL
one	NULL
pathway	NULL
during	NULL
early	NULL
Th	NULL
development	NULL
,	NULL
producing	NULL
a	NULL
stable	NULL
divergence	NULL
in	NULL
cytokine	NULL
profiles	NULL
.	NULL

Introduction	NULL
Interferon	NULL
y	NULL
(	NULL
IFNy	NULL
)	NULL
protects	NULL
against	NULL
many	NULL
viral	NULL
and	NULL
intracellular	NULL
pathogens	NULL
through	NULL
pleiotropic	NULL
effects	NULL
on	NULL
both	NULL
innate	NULL
and	NULL
specific	NULL
immune	NULL
cells	NULL
(	NULL
Bach	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
important	NULL
sources	NULL
of	NULL
IFNy	NULL
are	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
,	NULL
CD8+*	NULL
cytolytic	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
CD4	NULL
*	NULL
T	NULL
helper	NULL
(	NULL
Th	NULL
)	NULL
1	NULL
subset	NULL
.	NULL

NK	NULL
cells	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
rapidly	NULL
produce	NULL
IFNy	NULL
following	NULL
primary	NULL
activation	NULL
,	NULL
whereas	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
undergo	NULL
a	NULL
period	NULL
of	NULL
development	NULL
that	NULL
determines	NULL
whether	NULL
type	NULL
I	NULL
or	NULL
II	NULL
cytokines	NULL
are	NULL
produced	NULL
(	NULL
Abbas	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Important	NULL
for	NULL
Thi	NULL
development	NULL
is	NULL
interleukin-12	NULL
(	NULL
IL-12	NULL
)	NULL
(	NULL
Hsieh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
;	NULL
Manetti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
produced	NULL
by	NULL
activated	NULL
macrophages	NULL
and	NULL
dendritic	NULL
cells	NULL
(	NULL
Macatonia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
1995	NULL
;	NULL
de	NULL
Saint-	NULL
Vis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
which	NULL
acts	NULL
through	NULL
a	NULL
mechanism	NULL
involving	NULL
Stat4	NULL
(	NULL
Bacon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Jacobson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Kaplan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Thierfelder	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

At	NULL
present	NULL
,	NULL
little	NULL
is	NULL
known	NULL
regarding	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Statd4	NULL
activation	NULL
influences	NULL
the	NULL
early	NULL
differentiation	NULL
processes	NULL
that	NULL
regulate	NULL
IFNy	NULL
production	NULL
by	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
molecular	NULL
basis	NULL
of	NULL
subset-restricted	NULL
IL-4	NULL
production	NULL
has	NULL
been	NULL
proposed	NULL
by	NULL
the	NULL
identification	NULL
of	NULL
£	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
(	NULL
email	NULL
:	NULL
murphy	NULL
@	NULL
immunology.wustledu	NULL
)	NULL
.	NULL

c-maf	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
GATA-3	NULL
(	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
as	NULL
Th2-specific	NULL
transcription	NULL
factors	NULL
.	NULL

C-maf	NULL
expression	NULL
is	NULL
selectively	NULL
increased	NULL
in	NULL
Th2	NULL
development	NULL
and	NULL
interacts	NULL
directly	NULL
with	NULL
the	NULL
proximal	NULL
IL-4	NULL
promoter	NULL
at	NULL
the	NULL
MARE	NULL
element	NULL
to	NULL
augment	NULL
transcription	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

GATA-3	NULL
,	NULL
also	NULL
expressed	NULL
by	NULL
naive	NULL
and	NULL
Th2	NULL
cells	NULL
but	NULL
not	NULL
Th1	NULL
cells	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
augment	NULL
transcription	NULL
of	NULL
the	NULL
IL-4	NULL
and	NULL
IL-5	NULL
genes	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
basis	NULL
for	NULL
Th2-selec-tive	NULL
expression	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
is	NULL
not	NULL
yet	NULL
understood	NULL
in	NULL
terms	NULL
of	NULL
responses	NULL
to	NULL
cytokines	NULL
such	NULL
as	NULL
IL-12	NULL
and	NULL
IL-4	NULL
that	NULL
control	NULL
T	NULL
helper	NULL
development	NULL
.	NULL

Nonetheless	NULL
,	NULL
collectively	NULL
c-maf	NULL
and	NULL
GATA-3	NULL
provide	NULL
a	NULL
basis	NULL
for	NULL
the	NULL
positive	NULL
regulation	NULL
of	NULL
several	NULL
Th2-specific	NULL
cytokine	NULL
genes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
basis	NULL
for	NULL
Th1-selective	NULL
expression	NULL
of	NULL
IFNy	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
firmly	NULL
linked	NULL
to	NULL
IL-12	NULL
or	NULL
to	NULL
Stat4	NULL
.	NULL

Studies	NULL
of	NULL
IFNy	NULL
regulation	NULL
have	NULL
identified	NULL
several	NULL
potential	NULL
positive	NULL
and	NULL
negative	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
{	NULL
Young	NULL
and	NULL
Hardy	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

However	NULL
,	NULL
most	NULL
current	NULL
information	NULL
is	NULL
based	NULL
on	NULL
transformed	NULL
tumor	NULL
models	NULL
,	NULL
and	NULL
which	NULL
of	NULL
these	NULL
elements	NULL
operate	NULL
in	NULL
Th1/Th2	NULL
regulation	NULL
has	NULL
not	NULL
been	NULL
addressed	NULL
.	NULL

A	NULL
proximal	NULL
element	NULL
interacts	NULL
with	NULL
CREB/ATF1	NULL
transcription	NULL
factors	NULL
,	NULL
but	NULL
these	NULL
factors	NULL
have	NULL
not	NULL
been	NULL
described	NULL
as	NULL
acting	NULL
in	NULL
a	NULL
subset-restricted	NULL
manner	NULL
(	NULL
Cippitelli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Penix	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Another	NULL
study	NULL
reported	NULL
a	NULL
positive	NULL
GATA-3	NULL
interaction	NULL
with	NULL
a	NULL
dis-tal	NULL
IFNy	NULL
promoter	NULL
element	NULL
(	NULL
Penix	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
but	NULL
preceded	NULL
the	NULL
recognition	NULL
that	NULL
GATA-3	NULL
was	NULL
present	NULL
in	NULL
Th2	NULL
but	NULL
not	NULL
Thi	NULL
cells	NULL
.	NULL

The	NULL
potential	NULL
repressor	NULL
YY-1	NULL
was	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
an	NULL
element	NULL
in	NULL
the	NULL
proximal	NULL
IFNy	NULL
promoter	NULL
{	NULL
Ye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
but	NULL
it	NULL
has	NULL
not	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
differentially	NULL
regulated	NULL
between	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Young	NULL
and	NULL
colleagues	NULL
identified	NULL
a	NULL
class	NULL
of	NULL
sites	NULL
interacting	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
possibly	NULL
NF-AT	NULL
factors	NULL
(	NULL
Sica	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Several	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
and	NULL
first	NULL
intron	NULL
of	NULL
the	NULL
IFNy	NULL
gene	NULL
were	NULL
identified	NULL
that	NULL
could	NULL
potentially	NULL
interact	NULL
with	NULL
STAT	NULL
factors	NULL
(	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
elements	NULL
were	NULL
nonconsensus	NULL
STAT	NULL
elements	NULL
that	NULL
weakly	NULL
interacted	NULL
with	NULL
several	NULL
STAT	NULL
factors	NULL
,	NULL
including	NULL
Stati	NULL
,	NULL
Stat4	NULL
,	NULL
and	NULL
Stat6	NULL
.	NULL

The	NULL
direct	NULL
role	NULL
for	NULL
Stat4	NULL
at	NULL
these	NULL
sites	NULL
in	NULL
Th1i-specific	NULL
IFNy	NULL
expression	NULL
was	NULL
not	NULL
established	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
report	NULL
several	NULL
novel	NULL
findings	NULL
.	NULL

First	NULL
,	NULL
we	NULL
describe	NULL
a	NULL
new	NULL
Stat4-dependent	NULL
process	NULL
by	NULL
which	NULL
IL-12	NULL
can	NULL
augment	NULL
IFNy	NULL
in	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
show	NULL
that	NULL
IL-12	NULL
signaling	NULL
via	NULL
Stat4	NULL
is	NULL
required	NULL
for	NULL
full	NULL
repression	NULL
of	NULL
GATA-3	NULL
in	NULL
Th1	NULL
cells	NULL
and	NULL
in	NULL
turn	NULL
that	NULL
GATA-3	NULL
acts	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
Thi	NULL
development	NULL
and	NULL
IFNy	NULL
production	NULL
.	NULL

The	NULL
inhibition	NULL
by	NULL
GATA-3	NULL
of	NULL
IFNy	NULL
production	NULL
is	NULL
not	NULL
simply	NULL
a	NULL
secondary	NULL
effect	NULL
of	NULL
GATA-3	NULL
on	NULL
IL-4	NULL
production	NULL
,	NULL
since	NULL
it	NULL
occurs	NULL
equally	NULL
in	NULL
IL-4-deficient	NULL
T	NULL
cells	NULL
and	NULL
by	NULL
a	NULL
cell-autonomous	NULL
mechanism	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
show	NULL
that	NULL
GATA-3	NULL
represses	NULL
IFNy	NULL
production	NULL
only	NULL
when	NULL
continuously	NULL
expressed	NULL
during	NULL
initial	NULL
naive	NULL
T	NULL
cell	NULL
development	NULL
but	NULL
not	NULL
when	NULL
reintroduced	NULL
into	NULL
Th1	NULL
cells	NULL
after	NULL
IL-12-induced	NULL
Thi	NULL
development	NULL
.	NULL

This	NULL
suggests	NULL
GATA-3	NULL
may	NULL
regulate	NULL
an	NULL
early	NULL
step	NULL
in	NULL
Thi	NULL
development	NULL
rather	NULL
than	NULL
directly	NULL
Immunity	NULL
746	NULL
A	NULL
WT	NULL
__	NULL
Stati	NULL
(	NULL
/-	NULL
)	NULL
Stat4	NULL
(	NULL
/-	NULL
)	NULL
[	NULL
~	NULL
mls	NULL
I	NULL
1	NULL
IL-12	NULL
$	NULL
00	NULL
soos	NULL
!	NULL

we	NULL
oz	NULL
Ce	NULL
cw	NULL
IL-4	NULL
=o	NULL
zoos	NULL
#	NULL
>	NULL
lFN-T	NULL
o	NULL
e	NULL
e.	NULL
GATA3	NULL
«	NULL
-	NULL
C	NULL
-	NULL
we	NULL
-	NULL
se	NULL
|	NULL
caro	NULL
:	NULL
|	NULL
#	NULL
»	NULL
@	NULL
B	NULL
WT	NULL
IL-4	NULL
(	NULL
-/-	NULL
)	NULL
Stat6	NULL
(	NULL
-/-	NULL
)	NULL
I	NULL
I	NULL
f~	NULL
1	NULL
I	NULL
4	NULL
IL-12	NULL
$	NULL
o	NULL
so	NULL
x	NULL
``	NULL
e	NULL
ox	NULL
&	NULL
``	NULL
``	NULL
s	NULL
;	NULL
30	NULL
g	NULL
IL-4	NULL
-	NULL
-o	NULL
+	NULL
-o	NULL
-	NULL
+	NULL
-	NULL
-+	NULL
IFN-y	NULL
@	NULL
0	NULL
+	NULL
-	NULL
@	NULL
ot	NULL
oc	NULL
g	NULL
o	NULL
GATA3	NULL
‘	NULL
wt	NULL
wee	NULL
te	NULL
‘	NULL
caro	NULL
``	NULL
|	NULL
as	NULL
ap	NULL
ap	NULL
«	NULL
p	NULL
as	NULL
an	NULL
a	NULL
»	NULL
co	NULL
ap	NULL
|	NULL
10	NULL
20	NULL
3	NULL
4	NULL
50	NULL
60	NULL
T	NULL
8	NULL
9	NULL
C	NULL
wT	NULL
IL-4	NULL
(	NULL
-/-	NULL
)	NULL
-_	NULL
Staté	NULL
(	NULL
-/-	NULL
)	NULL
[	NULL
o	NULL
1	NULL
I	NULL
1	NULL
ILB	NULL
0	NULL
#	NULL
o-	NULL
o-	NULL
#	NULL
o-	NULL
o	NULL
>	NULL
#	NULL
o.	NULL
o.	NULL
II	NULL
|	NULL
s	NULL
e	NULL
ano	NULL
s	NULL
oe	NULL
#	NULL
2	NULL
zo	NULL
so	NULL
FFN-T	NULL
q	NULL
;	NULL
¢	NULL
-	NULL
6	NULL
%	NULL
£	NULL
GaATA3	NULL
«	NULL
man	NULL
=	NULL
<	NULL
-	NULL
)	NULL
455c0	NULL
Figure	NULL
1	NULL
.	NULL

IL-12	NULL
Inhibits	NULL
GATA-3	NULL
Expression	NULL
during	NULL
Thi	NULL
Development	NULL
(	NULL
A	NULL
)	NULL
T	NULL
cells	NULL
from	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
,	NULL
Stat1	NULL
(	NULL
-/-	NULL
)	NULL
,	NULL
or	NULL
Statd4	NULL
(	NULL
-/-	NULL
)	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
were	NULL
stimulated	NULL
with	NULL
0.3	NULL
WM	NULL
OVA	NULL
peptide	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
cytokines	NULL
(	NULL
+	NULL
)	NULL
or	NULL
anti-	NULL
cytokine	NULL
antibodies	NULL
(	NULL
-	NULL
)	NULL
for	NULL
48	NULL
hr	NULL
and	NULL
harvested	NULL
,	NULL
and	NULL
Northern	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Experimental	NULL
Procedures	NULL
.	NULL

(	NULL
B	NULL
)	NULL
T	NULL
cells	NULL
from	NULL
wild-type	NULL
and	NULL
IL-4	NULL
(	NULL
-/-	NULL
)	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
were	NULL
stimulated	NULL
with	NULL
OVA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
cytokines	NULL
(	NULL
+	NULL
)	NULL
or	NULL
anti-cytokines	NULL
antibodies	NULL
(	NULL
-	NULL
)	NULL
,	NULL
or	NULL
without	NULL
addition	NULL
(	NULL
gh	NULL
)	NULL
for	NULL
48	NULL
hr	NULL
.	NULL

Con	NULL
A	NULL
was	NULL
used	NULL
to	NULL
stimulate	NULL
splenocytes	NULL
purified	NULL
from	NULL
Stat6	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
not	NULL
transgenic	NULL
for	NULL
DO11.10	NULL
TCR	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
48	NULL
hr	NULL
later	NULL
.	NULL

Northern	NULL
analysis	NULL
was	NULL
done	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
T	NULL
cells	NULL
(	NULL
10	NULL
'	NULL
cells/lane	NULL
)	NULL
from	NULL
(	NULL
B	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
for	NULL
GATA-3	NULL
protein	NULL
expression	NULL
.	NULL

repressing	NULL
the	NULL
IFNy	NULL
promoter	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
our	NULL
data	NULL
that	NULL
GATA-3	NULL
inhibits	NULL
IL-12	NULL
receptor	NULL
expression	NULL
but	NULL
does	NULL
not	NULL
inhibit	NULL
reporter	NULL
activity	NULL
of	NULL
the	NULL
IFNy	NULL
promoter	NULL
.	NULL

Finally	NULL
,	NULL
reintroduction	NULL
of	NULL
GATA-3	NULL
into	NULL
Th1	NULL
cells	NULL
,	NULL
even	NULL
as	NULL
early	NULL
as	NULL
7	NULL
days	NULL
after	NULL
priming	NULL
,	NULL
fails	NULL
to	NULL
induce	NULL
IL-4	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
GATA-3	NULL
alone	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
IL-4	NULL
production	NULL
and	NULL
may	NULL
be	NULL
required	NULL
to	NULL
act	NULL
during	NULL
a	NULL
temporally	NULL
restricted	NULL
window	NULL
of	NULL
development	NULL
.	NULL

Results	NULL
Complete	NULL
Repression	NULL
of	NULL
GATA-3	NULL
in	NULL
Developing	NULL
Naive	NULL
T	NULL
Cells	NULL
Requires	NULL
IL-12	NULL
and	NULL
Stat4	NULL
GATA-3	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
Th2-specific	NULL
factor	NULL
that	NULL
could	NULL
positively	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
both	NULL
IL-4	NULL
and	NULL
IL-5	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Zheng	NULL
and	NULL
colleagues	NULL
used	NULL
RT-PCR	NULL
to	NULL
show	NULL
that	NULL
GATA-3	NULL
was	NULL
present	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
increased	NULL
during	NULL
Th2	NULL
development	NULL
and	NULL
extinguished	NULL
during	NULL
Thi	NULL
development	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
GATA-3	NULL
during	NULL
Th1	NULL
development	NULL
could	NULL
result	NULL
either	NULL
because	NULL
IL-4	NULL
is	NULL
required	NULL
for	NULL
its	NULL
maintenance	NULL
or	NULL
because	NULL
IL-12	NULL
is	NULL
required	NULL
for	NULL
its	NULL
suppression	NULL
.	NULL

To	NULL
distinguish	NULL
these	NULL
possibilities	NULL
we	NULL
examined	NULL
GATA-3	NULL
expression	NULL
during	NULL
development	NULL
of	NULL
naive	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
activated	NULL
under	NULL
a	NULL
variety	NULL
of	NULL
conditions	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

First	NULL
,	NULL
GATA-3	NULL
expression	NULL
is	NULL
maintained	NULL
even	NULL
when	NULL
developing	NULL
T	NULL
cells	NULL
are	NULL
activated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-4	NULL
and	NULL
IL-12	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
a	NULL
condition	NULL
that	NULL
does	NULL
not	NULL
generate	NULL
IL-4-producing	NULL
T	NULL
cells	NULL
.	NULL

GATA-3	NULL
is	NULL
enhanced	NULL
by	NULL
IL-4	NULL
addition	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
Zheng	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

IFNy	NULL
slightly	NULL
reduced	NULL
GATA-3	NULL
expression	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
but	NULL
addition	NULL
of	NULL
IL-12	NULL
produced	NULL
complete	NULL
loss	NULL
of	NULL
GATA-3	NULL
mRNA	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
complete	NULL
extinction	NULL
of	NULL
GATA-3	NULL
mRNA	NULL
caused	NULL
by	NULL
IL-12	NULL
involves	NULL
both	NULL
Stat4	NULL
and	NULL
Stati	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

In	NULL
DO11.10	NULL
T	NULL
cells	NULL
lacking	NULL
either	NULL
Stati	NULL
or	NULL
Stat4	NULL
,	NULL
IL-12	NULL
treatment	NULL
did	NULL
not	NULL
completely	NULL
repress	NULL
GATA-3	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
,	NULL
but	NULL
rather	NULL
GATA-3	NULL
mRNA	NULL
remained	NULL
at	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
T	NULL
cells	NULL
not	NULL
exposed	NULL
to	NULL
IL-12	NULL
.	NULL

Because	NULL
the	NULL
effects	NULL
of	NULL
IL-12	NULL
were	NULL
potentially	NULL
a	NULL
result	NULL
secondary	NULL
to	NULL
changes	NULL
in	NULL
IL-4	NULL
levels	NULL
rather	NULL
than	NULL
direct	NULL
effects	NULL
of	NULL
IL-12	NULL
signaling	NULL
,	NULL
we	NULL
repeated	NULL
these	NULL
experiments	NULL
using	NULL
DO11.10	NULL
mice	NULL
crossed	NULL
to	NULL
the	NULL
IL-4-deficient	NULL
background	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

IL-12	NULL
inhibited	NULL
GATA-3	NULL
expression	NULL
in	NULL
wild-type	NULL
DO11.10	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
1B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
as	NULL
before	NULL
but	NULL
also	NULL
in	NULL
IL-4-deficient	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
maintenance	NULL
of	NULL
GATA-3	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
during	NULL
early	NULL
activation	NULL
of	NULL
primary	NULL
cells	NULL
(	NULL
Figure	NULL
1B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
in	NULL
concanavalin	NULL
A	NULL
(	NULL
Con	NULL
A	NULL
)	NULL
activated	NULL
Staté-deficient	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
IL-12	NULL
reduced	NULL
GATA-3	NULL
expression	NULL
,	NULL
(	NULL
Figure	NULL
1B	NULL
,	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
Western	NULL
analysis	NULL
confirmed	NULL
that	NULL
IL-12	NULL
dramatically	NULL
inhibited	NULL
GATA-3	NULL
protein	NULL
expression	NULL
independently	NULL
of	NULL
IL-4	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Repression	NULL
of	NULL
GATA-3	NULL
protein	NULL
by	NULL
IL-12	NULL
occurred	NULL
in	NULL
IL-4-deficient	NULL
T	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
Staté-deficient	NULL
T	NULL
cells	NULL
{	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
GATA-3	NULL
expression	NULL
induced	NULL
by	NULL
IL-4	NULL
appeared	NULL
Stat6-dependent	NULL
(	NULL
Figure	NULL
1B	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
;	NULL
Figure	NULL
1C	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
as	NULL
well	NULL
.	NULL

GATA-3	NULL
Expression	NULL
Blocks	NULL
Thi	NULL
Development	NULL
and	NULL
IFNy	NULL
Production	NULL
Independently	NULL
of	NULL
IL-4	NULL
The	NULL
IL-12-dependent	NULL
inhibition	NULL
of	NULL
GATA-3	NULL
suggests	NULL
a	NULL
reciprocal	NULL
repressive	NULL
role	NULL
for	NULL
GATA-3	NULL
in	NULL
Thi	NULL
development	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
maintain	NULL
GATA-3	NULL
expression	NULL
during	NULL
IL-12-induced	NULL
Thi	NULL
development	NULL
.	NULL

We	NULL
generated	NULL
a	NULL
bi-cistronic	NULL
retrovirus	NULL
coexpressing	NULL
GATA-3	NULL
and	NULL
GFP	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

This	NULL
retrovirus	NULL
expresses	NULL
GATA-3	NULL
under	NULL
control	NULL
of	NULL
MSCV	NULL
LTR	NULL
that	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
IL-12	NULL
,	NULL
thus	NULL
maintaining	NULL
GATA-3	NULL
expression	NULL
during	NULL
early	NULL
T	NULL
cell	NULL
IL-4-Independent	NULL
Th1	NULL
Repression	NULL
by	NULL
GATA-3	NULL
747	NULL
A	NULL
MSV	NULL
Xhop	NULL
|	NULL
MScy	NULL
D	NULL
WT	NULL
WT	NULL
IL4	NULL
(	NULL
/	NULL
)	NULL
WT	NULL
GFP-RV	NULL
(	NULL
empty	NULL
vector	NULL
)	NULL
|5	NULL
LTR|	NULL
{	NULL
NIGER	NULL
3	NULL
'	NULL
LTR	NULL
Thi	NULL
Th2	NULL
Thi	NULL
Thi	NULL
SLT	NULL
lires	NULL
\	NULL
[	NULL
s	NULL
TR	NULL
a	NULL
GATAE-RV	NULL
5	NULL
'	NULL
LTR	NULL
|	NULL
GATA3	NULL
s	NULL
tR	NULL
4	NULL
4	NULL
aa	NULL
t	NULL
5	NULL
A	NULL
AL	NULL
L4	NULL
A	NULL
e	NULL
A	NULL
A	NULL
%	NULL
%	NULL
R	NULL
A	NULL
B	NULL
GFP-RV	NULL
GATAI-RV	NULL
f	NULL
55	NULL
kD	NULL
4	NULL
ece	NULL
-	NULL
ac	NULL
10	NULL
20	NULL
3	NULL
4	NULL
50	NULL
6	NULL
E	NULL
L2	NULL
_	NULL
2500	NULL
E	NULL
-	NULL
2000	NULL
&	NULL
€	NULL
-	NULL
1500	NULL
>	NULL
6	NULL
1000	NULL
t	NULL
500	NULL
<	NULL
34	NULL
<	NULL
34	NULL
D	NULL
C	NULL
®	NULL
a	NULL
a	NULL
7	NULL
E	NULL
6	NULL
it	NULL
o	NULL
5	NULL
a	NULL
£	NULL
4	NULL
é	NULL
``	NULL
1	NULL
Untransfected	NULL
GFP-RV	NULL
z	NULL
g	NULL
l—L	NULL
‘	NULL
J—l	NULL
o	NULL
¥	NULL
camry	NULL
3	NULL
EZ	NULL
.	NULL

”	NULL
N	NULL
o	NULL
7	NULL
Ga	NULL
C	NULL
(	NULL
hrg	NULL
,	NULL
I	NULL
*	NULL
nt	NULL
/	NULL
mm	NULL
*	NULL
42	NULL
tr	NULL
%	NULL
,	NULL
s	NULL
T	NULL
``	NULL
5	NULL
«	NULL
Me	NULL
l	NULL
reads	NULL
ti	NULL
___	NULL
30	NULL
GFP	NULL
Thi	NULL
Th2	NULL
Figure	NULL
2	NULL
.	NULL

GATA-3	NULL
Inhibits	NULL
IL-12-Induced	NULL
Thi	NULL
Development	NULL
and	NULL
IFNy	NULL
Production	NULL
(	NULL
A	NULL
)	NULL
Retroviral	NULL
constructs	NULL
.	NULL

The	NULL
retrovirus	NULL
vector	NULL
containing	NULL
only	NULL
GFP	NULL
(	NULL
GFP-RV	NULL
)	NULL
was	NULL
used	NULL
in	NULL
all	NULL
experiments	NULL
to	NULL
control	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
retrovirus	NULL
infection	NULL
.	NULL

The	NULL
GATA-3-expressing	NULL
retrovirus	NULL
(	NULL
GATA3-RV	NULL
)	NULL
contains	NULL
murine	NULL
GATA-3	NULL
cDNA	NULL
placed	NULL
behind	NULL
the	NULL
murine	NULL
stem	NULL
cell	NULL
virus	NULL
(	NULL
MSCV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
and	NULL
upstream	NULL
of	NULL
the	NULL
internal	NULL
ribosomal	NULL
entry	NULL
site	NULL
(	NULL
IRES	NULL
)	NULL
from	NULL
encephalomyocarditis	NULL
virus	NULL
in	NULL
GFP-RV	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DO11.10	NULL
TCR-transgenic	NULL
T	NULL
cells	NULL
were	NULL
infected	NULL
on	NULL
day	NULL
1	NULL
of	NULL
primary	NULL
activation	NULL
by	NULL
either	NULL
control	NULL
(	NULL
GFP-RV	NULL
)	NULL
or	NULL
GATA-3-expressing	NULL
(	NULL
GATA3-RV	NULL
)	NULL
retrovirus	NULL
,	NULL
treated	NULL
using	NULL
Th1-inducing	NULL
and	NULL
Th2-inducing	NULL
conditions	NULL
as	NULL
indicated	NULL
(	NULL
Experimental	NULL
Procedures	NULL
)	NULL
,	NULL
harvested	NULL
on	NULL
day	NULL
7	NULL
,	NULL
stained	NULL
with	NULL
anti-CD4-PE	NULL
(	NULL
Pharmingen	NULL
)	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
two-color	NULL
FACS	NULL
.	NULL

Numbers	NULL
represent	NULL
the	NULL
quadrant	NULL
statistics	NULL
of	NULL
live-gated	NULL
events	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
then	NULL
sorted	NULL
for	NULL
GFP/CD4	NULL
expression	NULL
.	NULL

(	NULL
C	NULL
)	NULL
GFP-positive	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
sorted	NULL
from	NULL
the	NULL
indicated	NULL
populations	NULL
in	NULL
(	NULL
B	NULL
)	NULL
were	NULL
reactivated	NULL
with	NULL
OVA/APCs	NULL
and	NULL
analyzed	NULL
after	NULL
3	NULL
days	NULL
for	NULL
GFP	NULL
expression	NULL
by	NULL
FACS	NULL
.	NULL

Data	NULL
is	NULL
presented	NULL
as	NULL
single-color	NULL
histograms	NULL
of	NULL
live	NULL
gated	NULL
events	NULL
.	NULL

The	NULL
negative	NULL
control	NULL
(	NULL
untransfected	NULL
)	NULL
was	NULL
a	NULL
noninfected	NULL
parallel	NULL
Thi	NULL
culture	NULL
from	NULL
the	NULL
same	NULL
experiment	NULL
.	NULL

(	NULL
D	NULL
)	NULL
GATA-3	NULL
expression	NULL
in	NULL
the	NULL
sorted	NULL
populations	NULL
from	NULL
(	NULL
C	NULL
)	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
analysis	NULL
7	NULL
days	NULL
after	NULL
restimulation	NULL
.	NULL

10	NULL
``	NULL
T	NULL
cells	NULL
from	NULL
the	NULL
indicated	NULL
transfection	NULL
were	NULL
stimulated	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
4	NULL
hr	NULL
before	NULL
lysis	NULL
for	NULL
Western	NULL
analysis	NULL
for	NULL
GATA-3	NULL
.	NULL

(	NULL
E	NULL
)	NULL
DO11.10	NULL
TCR-transgenic	NULL
primary	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
under	NULL
either	NULL
Th1	NULL
or	NULL
Th2	NULL
conditions	NULL
as	NULL
indicated	NULL
and	NULL
infected	NULL
by	NULL
GFP-RV	NULL
,	NULL
GATA3-RV	NULL
on	NULL
day	NULL
1	NULL
.	NULL

GPF+*	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
on	NULL
day	NULL
7	NULL
and	NULL
stimulated	NULL
with	NULL
OVA	NULL
and	NULL
APCs	NULL
,	NULL
expanded	NULL
for	NULL
7	NULL
days	NULL
,	NULL
harvested	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
stimulated	NULL
at	NULL
1.25	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
with	NULL
0.3	NULL
wM	NULL
OVA	NULL
and	NULL
irradiated	NULL
BALB/c	NULL
splenocytes	NULL
as	NULL
APCs	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
after	NULL
48	NULL
hr	NULL
and	NULL
IFNy	NULL
and	NULL
IL-4	NULL
production	NULL
determined	NULL
by	NULL
ELISA	NULL
as	NULL
described	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
six	NULL
other	NULL
independent	NULL
retroviral	NULL
transfection	NULL
experiments	NULL
.	NULL

development	NULL
.	NULL

Naive	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
antigen	NULL
under	NULL
conditions	NULL
to	NULL
induce	NULL
either	NULL
Thi	NULL
or	NULL
Th2	NULL
development	NULL
and	NULL
were	NULL
infected	NULL
with	NULL
retrovirus	NULL
on	NULL
day	NULL
1	NULL
after	NULL
primary	NULL
activation	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
develop	NULL
until	NULL
day	NULL
7	NULL
,	NULL
when	NULL
retroviral	NULL
infection	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
GFP	NULL
expression	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
and	NULL
infected	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
.	NULL

CD4+*	NULL
GFP+	NULL
TCR	NULL
transgenic	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
to	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
GATA-3	NULL
under	NULL
LTR	NULL
control	NULL
achieved	NULL
levels	NULL
of	NULL
protein	NULL
expression	NULL
very	NULL
similar	NULL
to	NULL
levels	NULL
expressed	NULL
by	NULL
native	NULL
Th2	NULL
cells	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
,	NULL
both	NULL
in	NULL
wild-type	NULL
DO11.10	NULL
T	NULL
cells	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
in	NULL
IL-4-deficient	NULL
DO11.10	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

To	NULL
control	NULL
for	NULL
any	NULL
effect	NULL
of	NULL
virus	NULL
infection	NULL
itself	NULL
,	NULL
all	NULL
experiments	NULL
were	NULL
done	NULL
using	NULL
GATA-3-expressing	NULL
retrovirus	NULL
(	NULL
GATA-3-RV	NULL
)	NULL
and	NULL
empty-retrovirus	NULL
expressing	NULL
only	NULL
GFP	NULL
(	NULL
GFP-RV	NULL
)	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Maintenance	NULL
of	NULL
GATA-3	NULL
expression	NULL
in	NULL
IL-12-treated	NULL
developing	NULL
T	NULL
cells	NULL
virtually	NULL
eliminated	NULL
subsequent	NULL
IFNy	NULL
production	NULL
(	NULL
Figure	NULL
2E	NULL
)	NULL
.	NULL

This	NULL
also	NULL
modestly	NULL
augmented	NULL
IL-4	NULL
production	NULL
but	NULL
did	NULL
not	NULL
fully	NULL
increase	NULL
levels	NULL
of	NULL
IL-4	NULL
to	NULL
that	NULL
of	NULL
Th2	NULL
cells	NULL
(	NULL
Figure	NULL
2E	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
GATA-3	NULL
expression	NULL
in	NULL
IL-4-treated	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
increase	NULL
IL-4	NULL
production	NULL
above	NULL
control	NULL
Th2	NULL
levels	NULL
.	NULL

To	NULL
explore	NULL
potential	NULL
mechanisms	NULL
of	NULL
this	NULL
GATA-3	NULL
action	NULL
,	NULL
we	NULL
examined	NULL
a	NULL
mutant	NULL
form	NULL
of	NULL
GATA-3	NULL
,	NULL
KRR	NULL
.	NULL

In	NULL
this	NULL
mutant	NULL
,	NULL
amino	NULL
acids	NULL
305-307	NULL
(	NULL
KRR	NULL
)	NULL
,	NULL
located	NULL
just	NULL
before	NULL
the	NULL
second	NULL
zinc	NULL
finger	NULL
domain	NULL
,	NULL
are	NULL
changed	NULL
to	NULL
AAA	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

This	NULL
mutant	NULL
was	NULL
reported	NULL
to	NULL
exert	NULL
a	NULL
dominant	NULL
negative	NULL
effect	NULL
on	NULL
a	NULL
synthetic	NULL
reporter	NULL
construct	NULL
containing	NULL
multimers	NULL
of	NULL
GATA	NULL
elements	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
but	NULL
to	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
KRR	NULL
GATA-3	NULL
mutant	NULL
in	NULL
IL-12-treated	NULL
developing	NULL
Thi	NULL
cells	NULL
caused	NULL
the	NULL
same	NULL
total	NULL
reduction	NULL
in	NULL
IFNy	NULL
and	NULL
slight	NULL
IL-4	NULL
augmentation	NULL
as	NULL
wild-type	NULL
GATA-3	NULL
(	NULL
Figure	NULL
2E	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
relevant	NULL
GATA-3	NULL
target	NULL
sites	NULL
in	NULL
developing	NULL
T	NULL
cells	NULL
are	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
KRR	NULL
mutation	NULL
unlike	NULL
the	NULL
multimerized	NULL
GATA	NULL
reporters	NULL
used	NULL
previously	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
but	NULL
nonetheless	NULL
reinforces	NULL
the	NULL
results	NULL
seen	NULL
for	NULL
wild-type	NULL
GATA-3	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
inhibition	NULL
of	NULL
IL-12-induced	NULL
IFNy	NULL
Immunity	NULL
748	NULL
Figure	NULL
3	NULL
.	NULL

GATA-3	NULL
Inhibits	NULL
IL-12-Induced	NULL
Th1	NULL
Development	NULL
by	NULL
an	NULL
IL-4-Independent	NULL
Mech-	NULL
WT	NULL
Thi	NULL
anism	NULL
(	NULL
A	NULL
)	NULL
Splenocytes	NULL
from	NULL
IL-4	NULL
(	NULL
-/-	NULL
)	NULL
TCR-transgenic	NULL
mice	NULL
were	NULL
activated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
infected	NULL
after	NULL
1	NULL
day	NULL
with	NULL
control	NULL
(	NULL
GFP-RV	NULL
)	NULL
or	NULL
GATA-3-expressing	NULL
(	NULL
GATA3-RV	NULL
)	NULL
retrovirus	NULL
.	NULL

Infected	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
sorting	NULL
GFP+	NULL
T	NULL
cells	NULL
on	NULL
day	NULL
7	NULL
and	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
2	NULL
and	NULL
GATA-3	NULL
expression	NULL
A	NULL
B	NULL
1600	NULL
80	NULL
1400	NULL
8	NULL
io	NULL
1200	NULL
@	NULL
600	NULL
=	NULL
RR	NULL
GFP-RV	NULL
E	NULL
500	NULL
£	NULL
1000	NULL
i	NULL
&	NULL
#	NULL
400	NULL
2	NULL
sop	NULL
|	NULL
C	NULL
camery	NULL
&	NULL
>	NULL
300	NULL
#	NULL
600	NULL
s	NULL
200	NULL
T_	NULL
400	NULL
100	NULL
200	NULL
h	NULL
0	NULL
25	NULL
1200	NULL
_L	NULL
1000	NULL
§	NULL
°	NULL
E	NULL
soo	NULL
a	NULL
8	NULL
as	NULL
B	NULL
1	NULL
4.	NULL
soo	NULL
1	NULL
&	NULL
&	NULL
400	NULL
0.5	NULL
0.03	NULL
<	NULL
0.03	NULL
0	NULL
Gy	NULL
Q	NULL
o	NULL
e.	NULL
t	NULL
s	NULL
A	NULL
.	NULL

03,9	NULL
AL	NULL
.	NULL

The	NULL
(	NULL
WT	NULL
)	NULL
-	NULL
anti-CD3	NULL
production	NULL
was	NULL
simply	NULL
the	NULL
result	NULL
of	NULL
increased	NULL
IL-4	NULL
production	NULL
,	NULL
we	NULL
repeated	NULL
these	NULL
experiments	NULL
with	NULL
IL-4-deficient	NULL
DO11.10	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Maintaining	NULL
GATA-3	NULL
expression	NULL
in	NULL
IL-12-treated	NULL
IL-4-deficient	NULL
DO11.10	NULL
T	NULL
cells	NULL
completely	NULL
inhibited	NULL
IFNy	NULL
production	NULL
compared	NULL
to	NULL
control	NULL
cells	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Inhibition	NULL
occurred	NULL
even	NULL
though	NULL
GATA-3	NULL
could	NULL
not	NULL
induce	NULL
IL-4	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
,	NULL
suggesting	NULL
an	NULL
IL-4-independent	NULL
mechanism	NULL
,	NULL
such	NULL
as	NULL
by	NULL
blockade	NULL
of	NULL
some	NULL
intrinsic	NULL
signaling	NULL
pathway	NULL
or	NULL
transcription	NULL
factor	NULL
.	NULL

IFNy	NULL
production	NULL
was	NULL
recently	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
not	NULL
only	NULL
by	NULL
TCR	NULL
but	NULL
induced	NULL
synergistically	NULL
by	NULL
IL-12	NULL
and	NULL
IL-18	NULL
(	NULL
Okamura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Robinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
GATA-3	NULL
might	NULL
differentially	NULL
interfere	NULL
with	NULL
these	NULL
pathways	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
GATA-3	NULL
inhibited	NULL
IFNy	NULL
production	NULL
stimulated	NULL
by	NULL
IL-12	NULL
and	NULL
IL-18	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
anti-CD3	NULL
,	NULL
in	NULL
both	NULL
wild-type	NULL
and	NULL
IL-4-deficient	NULL
DO11.10	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

GATA-3	NULL
expression	NULL
inhibited	NULL
all	NULL
modes	NULL
of	NULL
IFNy	NULL
induction	NULL
,	NULL
TCR-dependent	NULL
and	NULL
cytokine-dependent	NULL
,	NULL
in	NULL
both	NULL
wild-type	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
and	NULL
IL-4-deficient	NULL
{	NULL
lower	NULL
panel	NULL
)	NULL
DO11.10	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
control	NULL
T	NULL
cells	NULL
showed	NULL
IFNy	NULL
production	NULL
in	NULL
response	NULL
to	NULL
both	NULL
IL-12/IL-18	NULL
treatment	NULL
and	NULL
to	NULL
anti-CD3	NULL
.	NULL

GATA-3	NULL
Inhibits	NULL
IL-12-Induced	NULL
IFNy	NULL
Production	NULL
by	NULL
a	NULL
Cell-Intrinsic	NULL
Mechanism	NULL
As	NULL
a	NULL
transcription	NULL
factor	NULL
,	NULL
GATA-3	NULL
could	NULL
potentially	NULL
augment	NULL
or	NULL
repress	NULL
numerous	NULL
cytokines	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
GATA-3	NULL
on	NULL
a	NULL
panel	NULL
of	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
factors	NULL
using	NULL
RNase	NULL
protection	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
substantial	NULL
reduction	NULL
in	NULL
IFNy	NULL
production	NULL
occurred	NULL
in	NULL
GATA-3-expressing	NULL
Th1	NULL
cells	NULL
relative	NULL
to	NULL
GFP-RV	NULL
controls	NULL
.	NULL

This	NULL
also	NULL
implies	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
IFNy	NULL
is	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
,	NULL
or	NULL
possibly	NULL
mRNA	NULL
stability	NULL
.	NULL

Importantly	NULL
,	NULL
three	NULL
other	NULL
Th1-specific	NULL
cytokines	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNF	NULL
«	NULL
)	NULL
,	NULL
TNFB	NULL
,	NULL
and	NULL
lymphotoxin	NULL
B	NULL
(	NULL
LTB	NULL
)	NULL
were	NULL
also	NULL
significantly	NULL
inhibited	NULL
by	NULL
maintenance	NULL
of	NULL
GATA-3	NULL
in	NULL
IL-12-induced	NULL
Th1	NULL
development	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

TNFR	NULL
and	NULL
LTB	NULL
showed	NULL
virtually	NULL
complete	NULL
repression	NULL
,	NULL
L4G	NULL
)	NULL
Thi	NULL
confirmed	NULL
by	NULL
Western	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
.	NULL

Cytokine	NULL
production	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
from	NULL
supernatants	NULL
taken	NULL
48	NULL
hr	NULL
after	NULL
stimulation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Wild-type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
IL-4-deficient	NULL
(	NULL
IL-4	NULL
(	NULL
-/-	NULL
)	NULL
)	NULL
DO11.10	NULL
T	NULL
cells	NULL
infected	NULL
with	NULL
GFP-RV	NULL
or	NULL
GATA3-RV	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
above	NULL
.	NULL

On	NULL
day	NULL
7	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-12	NULL
(	NULL
10	NULL
U/ml	NULL
!	NULL
)	NULL

or	NULL
IL-18	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
plate-bound	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

At	NULL
48	NULL
hr	NULL
,	NULL
supernatants	NULL
were	NULL
harvested	NULL
and	NULL
IFNy	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

The	NULL
asterisks	NULL
indicate	NULL
that	NULL
the	NULL
IFNy	NULL
was	NULL
less	NULL
than	NULL
3	NULL
ng/ml	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
additional	NULL
independent	NULL
experiments	NULL
.	NULL

+	NULL
anti-CD3	NULL
whereas	NULL
TNFa	NULL
showed	NULL
approximately	NULL
5-	NULL
to	NULL
10-fold	NULL
inhibition	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

As	NULL
before	NULL
,	NULL
this	NULL
inhibition	NULL
occurred	NULL
independently	NULL
of	NULL
IL-4	NULL
,	NULL
since	NULL
these	NULL
effects	NULL
were	NULL
identical	NULL
when	NULL
repeated	NULL
using	NULL
IL-4-deficient	NULL
DO11.10	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
experiments	NULL
confirmed	NULL
previously	NULL
reported	NULL
augmentation	NULL
of	NULL
several	NULL
Th2-specific	NULL
cytokines	NULL
by	NULL
GATA-3	NULL
,	NULL
including	NULL
the	NULL
augmentation	NULL
of	NULL
IL-4	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
and	NULL
IL-6	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
a	NULL
previous	NULL
report	NULL
that	NULL
IL-5	NULL
,	NULL
and	NULL
IL-13	NULL
were	NULL
not	NULL
influenced	NULL
by	NULL
GATA-3	NULL
(	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
,	NULL
we	NULL
find	NULL
augmentation	NULL
of	NULL
mRNA	NULL
for	NULL
each	NULL
of	NULL
these	NULL
cytokines	NULL
,	NULL
even	NULL
in	NULL
IL-4-deficient	NULL
DO11.10	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
a	NULL
direct	NULL
role	NULL
of	NULL
GATA-3	NULL
,	NULL
rather	NULL
than	NULL
indirectly	NULL
inducing	NULL
these	NULL
Th2	NULL
cytokines	NULL
via	NULL
IL-4	NULL
production	NULL
.	NULL

These	NULL
findings	NULL
extend	NULL
the	NULL
previous	NULL
findings	NULL
for	NULL
GATA-3	NULL
in	NULL
controlling	NULL
Th2	NULL
cytokine	NULL
expression	NULL
,	NULL
while	NULL
demonstrating	NULL
a	NULL
novel	NULL
IL-4-independent	NULL
inhibition	NULL
of	NULL
IL-12-induced	NULL
Th1	NULL
development	NULL
.	NULL

Since	NULL
some	NULL
GATA-3-induced	NULL
cytokines	NULL
besides	NULL
IL-4	NULL
could	NULL
potentially	NULL
inhibit	NULL
IFNy	NULL
production	NULL
,	NULL
we	NULL
asked	NULL
if	NULL
this	NULL
inhibition	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
extracellular	NULL
milieu	NULL
or	NULL
rather	NULL
could	NULL
act	NULL
in	NULL
a	NULL
cell-autonomous	NULL
manner	NULL
.	NULL

By	NULL
analyzing	NULL
IFNy	NULL
production	NULL
at	NULL
the	NULL
single-cell	NULL
level	NULL
,	NULL
we	NULL
compared	NULL
intracellular	NULL
IFNy	NULL
production	NULL
in	NULL
DO11.10	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
either	NULL
infected	NULL
or	NULL
uninfected	NULL
by	NULL
retrovirus	NULL
while	NULL
developing	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
culture	NULL
induced	NULL
to	NULL
undergo	NULL
Thi	NULL
development	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Three-color	NULL
FACS	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
discriminate	NULL
whether	NULL
T	NULL
cells	NULL
had	NULL
been	NULL
infected	NULL
with	NULL
retrovirus	NULL
or	NULL
not	NULL
and	NULL
to	NULL
determine	NULL
the	NULL
level	NULL
of	NULL
intracellular	NULL
IFNy	NULL
production	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Infection	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
GFP-RV	NULL
control	NULL
virus	NULL
did	NULL
not	NULL
diminish	NULL
IFNy	NULL
production	NULL
of	NULL
infected	NULL
T	NULL
cells	NULL
compared	NULL
to	NULL
uninfected	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
4B	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
infection	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
GATA-3-expressing	NULL
retrovirus	NULL
significantly	NULL
reduced	NULL
intracellular	NULL
IFNy	NULL
production	NULL
of	NULL
the	NULL
infected	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
the	NULL
uninfected	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
same	NULL
culture	NULL
(	NULL
Figure	NULL
4B	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
despite	NULL
augmentation	NULL
in	NULL
certain	NULL
Th2-type	NULL
cytokines	NULL
induced	NULL
by	NULL
GATA-3	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
IL-12-induced	NULL
IFNy	NULL
is	NULL
largely	NULL
mediated	NULL
by	NULL
GATA-3	NULL
directly	NULL
within	NULL
the	NULL
T	NULL
cell	NULL
.	NULL

IL-4-Independent	NULL
Th1	NULL
Repression	NULL
by	NULL
GATA-3	NULL
749	NULL
A	NULL
WTO	NULL
wT	NULL
IL4	NULL
(	NULL
/	NULL
)	NULL
WT	NULL
WT	NULL
Figure	NULL
4	NULL
.	NULL

GATA-3	NULL
Affects	NULL
Expression	NULL
of	NULL
Sev-|TL|¥IE|	NULL
lﬂnﬁul	NULL
eral	NULL
Cytokine	NULL
Genes	NULL
in	NULL
IL-12-Induced	NULL
Th1	NULL
$	NULL
B	NULL
&	NULL
%	NULL
.	NULL

a	NULL
*	NULL
a	NULL
a	NULL
%	NULL
Cells	NULL
by	NULL
an	NULL
IL-4-Independent	NULL
Mechanism	NULL
*	NULL
%	NULL
419—6	NULL
To	NULL
~	NULL
t	NULL
t	NULL
t	NULL
t	NULL
21	NULL
%	NULL
%	NULL
%	NULL
%	NULL
A	NULL
*	NULL
%	NULL
R	NULL
%	NULL
(	NULL
A	NULL
)	NULL
Primary	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
IL-4	NULL
(	NULL
-/-	NULL
)	NULL
DO11.10	NULL
T	NULL
cells	NULL
infected	NULL
with	NULL
control	NULL
(	NULL
GFP-TNF~ﬁ	NULL
im	NULL
W	NULL
.RV	NULL
)	NULL
or	NULL
GATA-3-expressing	NULL
(	NULL
GATIAS-RV	NULL
)	NULL
{	NULL
rim-S	NULL
induced	NULL
under	NULL
Th1	NULL
or	NULL
Th2	NULL
conditions	NULL
as	NULL
indi-Ll-B	NULL
im	NULL
cated	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
.	NULL

T	NULL
cells	NULL
purified	NULL
by	NULL
sorting	NULL
were	NULL
later	NULL
stimulated	NULL
TNFh	NULL
i	NULL
|U	NULL
[	NULL
]	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
4	NULL
hr	NULL
as	NULL
described	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
RNA	NULL
purified	NULL
,	NULL
and	NULL
RNase	NULL
IL-6	NULL
i	NULL
»	NULL
ws	NULL
IL-4	NULL
i	NULL
>	NULL
protection	NULL
done	NULL
as	NULL
described	NULL
in	NULL
Experimental	NULL
IL-5	NULL
Proced.ures	NULL
.	NULL

IFN-	NULL
,	NULL
i	NULL
»	NULL
._	NULL
|	NULL
(	NULL
B	NULL
)	NULL
Primary	NULL
T	NULL
cells	NULL
from	NULL
DO11.10	NULL
TCR-¥	NULL
IL-10-	NULL
|	NULL
transgenic	NULL
mice	NULL
were	NULL
stimulated	NULL
using	NULL
0.3	NULL
IL-1	NULL
3	NULL
|	NULL
uM	NULL
OVA	NULL
peptide	NULL
and	NULL
infected	NULL
with	NULL
control	NULL
(	NULL
GFP-RV	NULL
)	NULL
or	NULL
GATA-3-expressing	NULL
(	NULL
GATA3-RV	NULL
)	NULL
virus	NULL
on	NULL
day	NULL
1	NULL
.	NULL

On	NULL
day	NULL
7	NULL
,	NULL
intracellular	NULL
IFNy	NULL
[	NULL
»	NULL
|	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Ex-TGF-	NULL
|	NULL
~	NULL
.	NULL

perimental	NULL
Procedures	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
B	NULL
F	NULL
as	NULL
two-color	NULL
dot	NULL
plots	NULL
showing	NULL
GFP	NULL
expres-t*	NULL
me	NULL
sion	NULL
(	NULL
FL1	NULL
)	NULL
versus	NULL
intracellular	NULL
IFNy	NULL
produc-IL-2	NULL
tion	NULL
(	NULL
FL2	NULL
)	NULL
of	NULL
events	NULL
gated	NULL
on	NULL
expression	NULL
of	NULL
CD4	NULL
(	NULL
FL3	NULL
)	NULL
.	NULL

ks	NULL
-	NULL
.	NULL

,	NULL
Im	NULL
IFN	NULL
y	NULL
Lad	NULL
|	NULL
L32	NULL
i	NULL
»	NULL
*	NULL
®	NULL
'	NULL
'	NULL
L32	NULL
%	NULL
>	NULL
GAP	NULL
D	NULL
-	NULL
tms	NULL
.	NULL

|	NULL
ugg	NULL
cma	NULL
@	NULL
t	NULL
tip	NULL
«	NULL
GAPDHI®	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
B	NULL
GFP-RV	NULL
GATA3-RV	NULL
°	NULL
&	NULL
14.5	NULL
Bd	NULL
5	NULL
Or	NULL
im	NULL
$	NULL
o	NULL
Cs	NULL
i	NULL
l	NULL
f	NULL
o	NULL
8	NULL
18.7	NULL
1.2	NULL
&	NULL
it	NULL
aat	NULL
-	NULL
as	NULL
=	NULL
an	NULL
0	NULL
go	NULL
``	NULL
10°	NULL
|	NULL
\_	NULL
--	NULL
--	NULL
-	NULL
»	NULL
GFP	NULL
However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
a	NULL
minor	NULL
non-cell-intrinsic	NULL
component	NULL
with	NULL
this	NULL
experiment	NULL
.	NULL

GATA-3	NULL
Inhibition	NULL
of	NULL
IL-12-Induced	NULL
IFNy	NULL
Is	NULL
Limited	NULL
to	NULL
an	NULL
Early	NULL
Developmental	NULL
Window	NULL
GATA-3	NULL
could	NULL
act	NULL
to	NULL
directly	NULL
repress	NULL
IFNy	NULL
transcription	NULL
or	NULL
could	NULL
act	NULL
only	NULL
developmentally	NULL
,	NULL
perhaps	NULL
by	NULL
interfering	NULL
with	NULL
a	NULL
Statd4-dependent	NULL
development	NULL
process	NULL
.	NULL

To	NULL
distinguish	NULL
these	NULL
possibilities	NULL
,	NULL
we	NULL
asked	NULL
at	NULL
what	NULL
stages	NULL
of	NULL
Thi	NULL
development	NULL
GATA-3	NULL
could	NULL
inhibit	NULL
IFNy	NULL
production	NULL
.	NULL

We	NULL
therefore	NULL
extended	NULL
our	NULL
previous	NULL
retroviral	NULL
infection	NULL
experiments	NULL
to	NULL
include	NULL
infection	NULL
on	NULL
day	NULL
1	NULL
,	NULL
as	NULL
before	NULL
,	NULL
but	NULL
also	NULL
on	NULL
day	NULL
8	NULL
after	NULL
primary	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
infection	NULL
of	NULL
a	NULL
fully	NULL
differentiated	NULL
Th1	NULL
clone	NULL
,	NULL
3F6	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

Cells	NULL
infected	NULL
with	NULL
GATA-3-expressing	NULL
or	NULL
GFP	NULL
control	NULL
retroviruses	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
for	NULL
GFP	NULL
expression	NULL
6	NULL
days	NULL
following	NULL
infection	NULL
,	NULL
expanded	NULL
for	NULL
1	NULL
week	NULL
,	NULL
and	NULL
cytokines	NULL
analyzed	NULL
by	NULL
ELISA	NULL
.	NULL

As	NULL
before	NULL
,	NULL
infection	NULL
of	NULL
primary	NULL
DO11.10	NULL
T	NULL
cells	NULL
on	NULL
day	NULL
1	NULL
inhibited	NULL
the	NULL
IL-12-induced	NULL
Thi	NULL
development	NULL
,	NULL
with	NULL
nearly	NULL
complete	NULL
inhibition	NULL
of	NULL
IFNy	NULL
production	NULL
and	NULL
40	NULL
%	NULL
augmentation	NULL
of	NULL
IL-4	NULL
production	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
upper	NULL
left	NULL
and	NULL
lower	NULL
left	NULL
panels	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
Thi	NULL
development	NULL
was	NULL
imposed	NULL
first	NULL
for	NULL
7	NULL
days	NULL
and	NULL
T	NULL
cells	NULL
then	NULL
infected	NULL
on	NULL
day	NULL
8	NULL
,	NULL
the	NULL
GATA-3-expressing	NULL
retrovirus	NULL
produced	NULL
only	NULL
a	NULL
20	NULL
%	NULL
reduction	NULL
in	NULL
IFNy	NULL
production	NULL
relative	NULL
to	NULL
control	NULL
T	NULL
Immunity	NULL
750	NULL
A	NULL
Day	NULL
1	NULL
Infection	NULL
Day	NULL
8	NULL
Infection	NULL
300	NULL
m	NULL
GFP-RV	NULL
p	NULL
cataz-Rv	NULL
f	NULL
--	NULL
A	NULL
)	NULL
a	NULL
20	NULL
‘	NULL
|	NULL
2	NULL
an	NULL
«	NULL
oor	NULL
IL-4	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

[	NULL
z	NULL
3F6	NULL
Infection	NULL
Figure	NULL
5	NULL
.	NULL

GATA-3	NULL
Does	NULL
Not	NULL
Directly	NULL
Repress	NULL
IFNy	NULL
Production	NULL
in	NULL
Differentiated	NULL
Th1	NULL
Cells	NULL
(	NULL
A	NULL
)	NULL
Primary	NULL
T	NULL
cells	NULL
from	NULL
wild-type	NULL
or	NULL
IL-4-deficient	NULL
IL-4	NULL
(	NULL
-/-	NULL
)	NULL
DO11.10	NULL
mice	NULL
were	NULL
activated	NULL
under	NULL
Th1	NULL
or	NULL
Th2	NULL
conditions	NULL
as	NULL
indicated	NULL
,	NULL
infected	NULL
with	NULL
control	NULL
(	NULL
GFP-RV	NULL
;	NULL
closed	NULL
bars	NULL
)	NULL
or	NULL
GATA3-expressing	NULL
(	NULL
GATA3-RV	NULL
;	NULL
open	NULL
bars	NULL
)	NULL
virus	NULL
on	NULL
day	NULL
1	NULL
(	NULL
left	NULL
panels	NULL
)	NULL
,	NULL
or	NULL
restimulated	NULL
on	NULL
day	NULL
7	NULL
and	NULL
infected	NULL
on	NULL
day	NULL
8	NULL
(	NULL
middle	NULL
panels	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Th1	NULL
clone	NULL
(	NULL
3F6	NULL
)	NULL
was	NULL
activated	NULL
by	NULL
0.3	NULL
M	NULL
OVA	NULL
and	NULL
APC	NULL
(	NULL
Experimental	NULL
Procedures	NULL
)	NULL
and	NULL
infected	NULL
after	NULL
1	NULL
day	NULL
with	NULL
GFP-RV	NULL
or	NULL
GATA3-RV	NULL
as	NULL
indicated	NULL
.	NULL

All	NULL
populations	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
on	NULL
day	NULL
6	NULL
after	NULL
infection	NULL
and	NULL
restimulated	NULL
as	NULL
described	NULL
above	NULL
.	NULL

48	NULL
hr	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
cytokines	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
GATA-3	NULL
expression	NULL
in	NULL
the	NULL
day	NULL
8	NULL
infected	NULL
T	NULL
cell	NULL
population	NULL
after	NULL
cell	NULL
sorting	NULL
was	NULL
examined	NULL
by	NULL
Western	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
2	NULL
.	NULL

(	NULL
C	NULL
)	NULL
A	NULL
luciferase	NULL
base	NULL
reporter	NULL
construct	NULL
containing	NULL
200	NULL
base	NULL
pairs	NULL
of	NULL
proximal	NULL
IFNy	NULL
promoter	NULL
cotransfected	NULL
with	NULL
CMV-Renilla	NULL
plas-	NULL
[	NULL
-o	NULL
PUL	NULL
___	NULL
L_	NULL
LEG	NULL
Thi	NULL
Tha	NULL
Thi	NULL
-	NULL
IL4	NULL
(	NULL
/	NULL
)	NULL
_	NULL
Tha	NULL
Th1	NULL
B	NULL
C	NULL
e	NULL
__	NULL
WT	NULL
IL4	NULL
(	NULL
-/-	NULL
)	NULL
U	NULL
Control	NULL
Thi	NULL
Thi	NULL
14	NULL
th	NULL
&	NULL
n	NULL
x	NULL
O	NULL
Luciferase	NULL
Fold	NULL
Induction	NULL
o	NULL
cells	NULL
infected	NULL
with	NULL
GFP-RV	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
middle	NULL
panels	NULL
)	NULL
.	NULL

This	NULL
20	NULL
%	NULL
inhibition	NULL
of	NULL
IFNy	NULL
production	NULL
was	NULL
also	NULL
seen	NULL
in	NULL
IL-4-deficient	NULL
T	NULL
cells	NULL
.	NULL

Significantly	NULL
,	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
no	NULL
detectable	NULL
increase	NULL
in	NULL
IL-4	NULL
production	NULL
was	NULL
seen	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lower	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
infection	NULL
of	NULL
3F6	NULL
by	NULL
GATA-3	NULL
retrovirus	NULL
produced	NULL
no	NULL
detectable	NULL
reduction	NULL
in	NULL
IFNy	NULL
and	NULL
,	NULL
notably	NULL
,	NULL
no	NULL
increase	NULL
in	NULL
IL-4	NULL
production	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
right	NULL
panels	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
GATA-3	NULL
protein	NULL
expression	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
analysis	NULL
for	NULL
the	NULL
day	NULL
8	NULL
infection	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
and	NULL
3F6	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
reintroduction	NULL
of	NULL
GATA-3	NULL
into	NULL
T	NULL
cells	NULL
after	NULL
Th1	NULL
development	NULL
has	NULL
occurred	NULL
but	NULL
does	NULL
not	NULL
result	NULL
in	NULL
inhibition	NULL
of	NULL
IFNy	NULL
or	NULL
the	NULL
augmentation	NULL
of	NULL
IL-4	NULL
production	NULL
.	NULL

Penix	NULL
and	NULL
colleagues	NULL
have	NULL
suggested	NULL
GATA-3	NULL
may	NULL
augment	NULL
IFNy	NULL
via	NULL
a	NULL
cis-acting	NULL
element	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
(	NULL
Penix	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
GATA-3	NULL
may	NULL
inhibit	NULL
IFNy	NULL
production	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
the	NULL
GATA-3	NULL
expression	NULL
could	NULL
augment	NULL
or	NULL
inhibit	NULL
luciferase	NULL
activity	NULL
of	NULL
an	NULL
IFNy	NULL
promoter	NULL
construct	NULL
that	NULL
includes	NULL
the	NULL
proposed	NULL
GATA-3	NULL
target	NULL
sequence	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

The	NULL
IFNy	NULL
reporter	NULL
construct	NULL
was	NULL
cotransfected	NULL
into	NULL
EL-4	NULL
cells	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
with	NULL
either	NULL
GATA-3	NULL
retrovirus	NULL
or	NULL
GFP-RV	NULL
control	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
normalized	NULL
by	NULL
cotransfection	NULL
of	NULL
a	NULL
CMV	NULL
promoter-	NULL
Renilla	NULL
luciferase	NULL
construct	NULL
.	NULL

GATA-3	NULL
had	NULL
minimal	NULL
effects	NULL
on	NULL
IFNy	NULL
promoter	NULL
activity	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

No	NULL
inhibition	NULL
was	NULL
seen	NULL
by	NULL
GATA-3	NULL
for	NULL
this	NULL
reporter	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
or	NULL
for	NULL
a	NULL
series	NULL
of	NULL
E	NULL
PMA+lonomycin	NULL
into	NULL
EL4	NULL
cells	NULL
(	NULL
Experimental	NULL
Procedures	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
(	NULL
closed	NULL
bars	NULL
)	NULL
or	NULL
without	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
4	NULL
hr	NULL
as	NULL
described	NULL
and	NULL
luciferase	NULL
activity	NULL
determined	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Transfection	NULL
was	NULL
normalized	NULL
by	NULL
CMV-Renilla	NULL
and	NULL
data	NULL
represent	NULL
fold-induction	NULL
compare	NULL
to	NULL
the	NULL
unstimulated	NULL
GFP-RV	NULL
vector	NULL
transfection	NULL
.	NULL

‘	NULL
mid	NULL
and	NULL
with	NULL
either	NULL
GFP-RV	NULL
or	NULL
GATA3-RV	NULL
GATA3-RV	NULL
larger	NULL
and	NULL
smaller	NULL
IFNy	NULL
promoter	NULL
constructs	NULL
,	NULL
including	NULL
a	NULL
3	NULL
kilobase	NULL
genomic	NULL
promoter	NULL
region	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
}	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
GATA-3	NULL
is	NULL
unlikely	NULL
to	NULL
exert	NULL
direct	NULL
repression	NULL
of	NULL
the	NULL
IFNy	NULL
promoter	NULL
but	NULL
rather	NULL
may	NULL
modify	NULL
a	NULL
developmental	NULL
program	NULL
whose	NULL
actions	NULL
are	NULL
temporally	NULL
restricted	NULL
.	NULL

GATA-3	NULL
Inhibits	NULL
IL-12	NULL
Signaling	NULL
by	NULL
Repressing	NULL
IL-12R	NULL
B2	NULL
Expression	NULL
IL-4-deficient	NULL
DO11.10	NULL
T	NULL
cells	NULL
infected	NULL
on	NULL
day	NULL
1	NULL
of	NULL
primary	NULL
antigen	NULL
activation	NULL
with	NULL
the	NULL
GATA-3	NULL
retrovirus	NULL
or	NULL
GFP-RV	NULL
control	NULL
were	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
for	NULL
GFP-positive	NULL
cells	NULL
and	NULL
expanded	NULL
and	NULL
analyzed	NULL
for	NULL
functional	NULL
IL-12	NULL
signaling	NULL
by	NULL
EMSA	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

For	NULL
T	NULL
cells	NULL
infected	NULL
by	NULL
GFP-RV	NULL
control	NULL
retrovirus	NULL
,	NULL
treatment	NULL
by	NULL
IL-12	NULL
in	NULL
primary	NULL
activation	NULL
produced	NULL
cells	NULL
exhibiting	NULL
the	NULL
expected	NULL
IL-12-induced	NULL
Stat4	NULL
complex	NULL
binding	NULL
the	NULL
M67	NULL
SIE	NULL
probe	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
(	NULL
Jacobson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
for	NULL
T	NULL
cells	NULL
infected	NULL
with	NULL
GATA-3	NULL
retrovirus	NULL
,	NULL
treatment	NULL
by	NULL
IL-12	NULL
during	NULL
primary	NULL
activation	NULL
produced	NULL
cells	NULL
that	NULL
failed	NULL
to	NULL
show	NULL
IL-12-induced	NULL
Stat4	NULL
complexes	NULL
(	NULL
Figure	NULL
6A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
IL-12R	NULL
B2	NULL
subunit	NULL
is	NULL
regulated	NULL
in	NULL
Th1/	NULL
Th2	NULL
development	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
,	NULL
1997	NULL
)	NULL
,	NULL
we	NULL
asked	NULL
if	NULL
GATA-3	NULL
expression	NULL
influenced	NULL
its	NULL
expression	NULL
using	NULL
Northern	NULL
analysis	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
We	NULL
found	NULL
that	NULL
IL-12-induced	NULL
Th1	NULL
cells	NULL
infected	NULL
by	NULL
GATA-3	NULL
retrovirus	NULL
on	NULL
day	NULL
1	NULL
of	NULL
primary	NULL
activation	NULL
later	NULL
showed	NULL
complete	NULL
absence	NULL
of	NULL
IL-12R8	NULL
subunit	NULL
mRNA	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
IL-12-treated	NULL
IL-4-Independent	NULL
Th1	NULL
Repression	NULL
by	NULL
GATA-3	NULL
751	NULL
A	NULL
B	NULL
GFP-RV	NULL
_	NULL
GaTA-RV	NULL
wi	NULL
wi	NULL
4	NULL
)	NULL
~~	NULL
Thi	NULL
--	NULL
Th2	NULL
-	NULL
Thi	NULL
,	NULL
o-	NULL
-I	NULL
~s	NULL
IL-12	NULL
-	NULL
g	NULL
L	NULL
AR	NULL
&	NULL
Q	NULL
®	NULL
5	NULL
t	NULL
t	NULL
t	NULL
t	NULL
1	NULL
%	NULL
%	NULL
%	NULL
%	NULL
IL-12Ra2	NULL
«	NULL
#	NULL
me	NULL
?	NULL

SIE	NULL
P1	NULL
p2|	NULL
®	NULL
(	NULL
nne	NULL
=	NULL
--	NULL
L-	NULL
yo	NULL
GAPDH	NULL
]	NULL
u	NULL
»	NULL
eus	NULL
@	NULL
@	NULL
D	NULL
ass	NULL
cm	NULL
10	NULL
2	NULL
3	NULL
405	NULL
C	NULL
Cc	NULL
***	NULL
|	NULL
Weal	NULL
tah	NULL
banh	NULL
thal	NULL
a	NULL
%	NULL
\	NULL
%	NULL
re-	NULL
B	NULL
%	NULL
1	NULL
#	NULL
s-	NULL
.4	NULL
Lump	NULL
]	NULL
?	NULL

‘	NULL
D	NULL
70	NULL
r	NULL
=	NULL
s	NULL
-	NULL
antiCD3	NULL
B	NULL
&	NULL
50	NULL
£	NULL
“	NULL
1	NULL
40	NULL
E	NULL
30	NULL
g	NULL
20	NULL
10	NULL
0	NULL
800	NULL
_	NULL
Too	NULL
+	NULL
antiCD3	NULL
E	NULL
500	NULL
®	NULL
500	NULL
£	NULL
~	NULL
.	NULL

400	NULL
2	NULL
300	NULL
*	NULL
209	NULL
100	NULL
0	NULL
G.	NULL
Q	NULL
oMie	NULL
tD	NULL
5	NULL
%	NULL
*	NULL
*+	NULL
q	NULL
‘	NULL
pz	NULL
’	NULL
L_	NULL
]	NULL
Media	NULL
IL-12	NULL
Figure	NULL
6	NULL
.	NULL

GATA-3	NULL
Inhibits	NULL
IL-12	NULL
Signaling	NULL
and	NULL
Represses	NULL
IL-12R	NULL
B2	NULL
Subunit	NULL
mRNA	NULL
Expression	NULL
(	NULL
A	NULL
)	NULL
IL-4	NULL
(	NULL
-/-	NULL
)	NULL
DO11.10	NULL
T	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
GFP-RV	NULL
or	NULL
GATA-3-RV	NULL
retrovirus	NULL
and	NULL
purified	NULL
and	NULL
expanded	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
3	NULL
.	NULL

The	NULL
indicated	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
IL-12	NULL
(	NULL
10	NULL
U/m	NULL
!	NULL
)	NULL

for	NULL
30	NULL
min	NULL
,	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
and	NULL
examined	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
m67	NULL
SIE	NULL
probe	NULL
for	NULL
Staid4	NULL
activation	NULL
,	NULL
or	NULL
Ea	NULL
probe	NULL
to	NULL
control	NULL
for	NULL
extract	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RNA	NULL
(	NULL
10	NULL
from	NULL
T	NULL
cells	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
4	NULL
were	NULL
analyzed	NULL
by	NULL
Northern	NULL
using	NULL
IL-12R	NULL
B2	NULL
cDNA	NULL
(	NULL
10°	NULL
cpm/ml	NULL
!	NULL
)	NULL

stripped	NULL
and	NULL
reprobed	NULL
with	NULL
GAPDH	NULL
as	NULL
described	NULL
to	NULL
control	NULL
for	NULL
RNA	NULL
integrity	NULL
.	NULL

T	NULL
cells	NULL
infected	NULL
by	NULL
GFP-RV	NULL
or	NULL
GATA3-RV	NULL
on	NULL
day	NULL
8	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
5	NULL
were	NULL
restimulated	NULL
by	NULL
OVA	NULL
and	NULL
APCs	NULL
and	NULL
after	NULL
7	NULL
days	NULL
either	NULL
(	NULL
C	NULL
)	NULL
total	NULL
RNA	NULL
purified	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
4	NULL
and	NULL
Northern	NULL
analysis	NULL
for	NULL
IL-12RB2	NULL
or	NULL
GAPDH	NULL
done	NULL
or	NULL
(	NULL
D	NULL
)	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
5	NULL
g/m	NULL
!	NULL
)	NULL

and	NULL
IL-12	NULL
(	NULL
10	NULL
U/m	NULL
!	NULL
)	NULL

as	NULL
indicated	NULL
and	NULL
48	NULL
hr	NULL
supernatants	NULL
harvested	NULL
and	NULL
IFNy	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

T	NULL
cells	NULL
infected	NULL
by	NULL
the	NULL
GFP	NULL
control	NULL
virus	NULL
.	NULL

GATA-3	NULL
inhibited	NULL
IL-12R	NULL
B2	NULL
expression	NULL
in	NULL
IL-4-deficient	NULL
DO11.10	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
above	NULL
.	NULL

Surprisingly	NULL
,	NULL
inhibition	NULL
of	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
by	NULL
GATA-3	NULL
was	NULL
evident	NULL
even	NULL
in	NULL
IL-12-treated	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
infected	NULL
on	NULL
day	NULL
8	NULL
after	NULL
primary	NULL
activation	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
,	NULL
a	NULL
situation	NULL
where	NULL
we	NULL
previously	NULL
found	NULL
no	NULL
inhibition	NULL
of	NULL
IFNy	NULL
production	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

Because	NULL
by	NULL
day	NULL
8	NULL
these	NULL
T	NULL
cells	NULL
have	NULL
already	NULL
been	NULL
exposed	NULL
to	NULL
IL-12	NULL
for	NULL
7	NULL
days	NULL
before	NULL
infection	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
developmental	NULL
action	NULL
of	NULL
Stat4	NULL
had	NULL
already	NULL
occurred	NULL
to	NULL
allow	NULL
TCR	NULL
inducible	NULL
IFNy	NULL
transcription	NULL
.	NULL

Thus	NULL
,	NULL
to	NULL
test	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
GATA-3-induced	NULL
down-regulation	NULL
of	NULL
IL-12R	NULL
B2	NULL
in	NULL
the	NULL
day	NULL
8	NULL
infection	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
IFNy	NULL
production	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
antiCD3	NULL
(	NULL
Figure	NULL
6D	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
anti-CD3-induced	NULL
IFNy	NULL
production	NULL
was	NULL
unaffected	NULL
by	NULL
GATA-3	NULL
in	NULL
T	NULL
cells	NULL
infected	NULL
on	NULL
day	NULL
8	NULL
(	NULL
Figure	NULL
6D	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
,	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-12	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
IL-12	NULL
alone	NULL
can	NULL
elicit	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
IFNy	NULL
production	NULL
(	NULL
Figure	NULL
6D	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
but	NULL
this	NULL
occurs	NULL
only	NULL
in	NULL
T	NULL
cells	NULL
infected	NULL
on	NULL
day	NULL
8	NULL
with	NULL
the	NULL
control	NULL
GFP	NULL
virus	NULL
and	NULL
not	NULL
with	NULL
GATA-3-expressing	NULL
retrovirus	NULL
.	NULL

Thus	NULL
,	NULL
reintroduction	NULL
of	NULL
GATA-3	NULL
into	NULL
differentiated	NULL
Thi	NULL
cells	NULL
can	NULL
inhibit	NULL
IL-12R	NULL
B2	NULL
expression	NULL
and	NULL
block	NULL
subsequent	NULL
IL-12-induced	NULL
responses	NULL
,	NULL
but	NULL
TCR-induced	NULL
IFNy	NULL
production	NULL
remains	NULL
intact	NULL
presumably	NULL
because	NULL
the	NULL
developmental	NULL
effects	NULL
of	NULL
Stat4	NULL
have	NULL
already	NULL
occurred	NULL
to	NULL
allow	NULL
TCR-induced	NULL
IFNy	NULL
production	NULL
.	NULL

The	NULL
above	NULL
results	NULL
imply	NULL
that	NULL
IL-12	NULL
represses	NULL
GATA-3	NULL
expression	NULL
in	NULL
developing	NULL
Thi	NULL
cells	NULL
and	NULL
that	NULL
GATA-3	NULL
inhibits	NULL
IL-12	NULL
receptor	NULL
expression	NULL
in	NULL
developing	NULL
Th2	NULL
cells	NULL
.	NULL

This	NULL
predicts	NULL
a	NULL
reciprocal	NULL
expression	NULL
pattern	NULL
of	NULL
these	NULL
genes	NULL
during	NULL
Thi	NULL
and	NULL
Th2	NULL
development	NULL
.	NULL

A	NULL
kinetic	NULL
analysis	NULL
of	NULL
GATA-3	NULL
and	NULL
IL-12	NULL
R	NULL
B2	NULL
mRNA	NULL
between	NULL
day	NULL
1	NULL
and	NULL
5	NULL
supports	NULL
this	NULL
prediction	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

In	NULL
primary	NULL
T	NULL
cells	NULL
induced	NULL
toward	NULL
Th2	NULL
development	NULL
,	NULL
GATA-3	NULL
mRNA	NULL
appears	NULL
induced	NULL
by	NULL
24	NULL
hr	NULL
,	NULL
whereas	NULL
in	NULL
Th1	NULL
development	NULL
,	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
is	NULL
just	NULL
detectable	NULL
at	NULL
24	NULL
hr	NULL
but	NULL
is	NULL
significantly	NULL
higher	NULL
at	NULL
48	NULL
hr	NULL
.	NULL

Notably	NULL
,	NULL
although	NULL
GATA-3	NULL
mRNA	NULL
is	NULL
highest	NULL
at	NULL
48	NULL
hr	NULL
,	NULL
we	NULL
observe	NULL
detectable	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
at	NULL
both	NULL
48	NULL
and	NULL
72	NULL
hr	NULL
even	NULL
in	NULL
Th2	NULL
conditions	NULL
,	NULL
but	NULL
which	NULL
declines	NULL
after	NULL
this	NULL
time	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
10	NULL
hr	NULL
24	NULL
hr	NULL
48	NULL
hr	NULL
72	NULL
hr	NULL
120	NULL
hr	NULL
y	NULL
'	NULL
%	NULL
ty-	NULL
xix	NULL
wr	NULL
,	NULL
p	NULL
&	NULL
A	NULL
4	NULL
4	NULL
A	NULL
4	NULL
A	NULL
&	NULL
%	NULL
3	NULL
%	NULL
%	NULL
[	NULL
313	NULL
3	NULL
,	NULL
a	NULL
)	NULL
*+	NULL
%	NULL
%	NULL
4	NULL
IL—12RB2	NULL
|	NULL
wae	NULL
wae	NULL
Siuc	NULL
‘	NULL
GaATA3	NULL
seee	NULL
-	NULL
w	NULL
-	NULL
--	NULL
‘	NULL
«	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
Figure	NULL
7	NULL
.	NULL

GATA-3	NULL
and	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
Expression	NULL
during	NULL
Early	NULL
Stages	NULL
of	NULL
Thi	NULL
and	NULL
Th2	NULL
Development	NULL
T	NULL
cells	NULL
fom	NULL
DO11.10	NULL
TCR	NULL
transgenic	NULL
mice	NULL
were	NULL
activated	NULL
using	NULL
0.3	NULL
wM	NULL
OVA	NULL
peptide	NULL
and	NULL
APCs	NULL
under	NULL
either	NULL
Th1i-	NULL
or	NULL
Th2-inducing	NULL
conditions	NULL
(	NULL
Experimental	NULL
Procedures	NULL
)	NULL
,	NULL
harvested	NULL
at	NULL
indicated	NULL
times	NULL
,	NULL
total	NULL
RNA	NULL
prepared	NULL
and	NULL
analyzed	NULL
for	NULL
GATA-3	NULL
,	NULL
IL-12R§B2	NULL
and	NULL
HPRT	NULL
expression	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

Immunity	NULL
752	NULL
that	NULL
some	NULL
IL-12	NULL
B2	NULL
mRNA	NULL
is	NULL
expressed	NULL
early	NULL
during	NULL
Th2	NULL
development	NULL
between	NULL
days	NULL
2	NULL
and	NULL
3	NULL
despite	NULL
early	NULL
GATA-3	NULL
induction	NULL
,	NULL
which	NULL
could	NULL
potentially	NULL
allow	NULL
IL-12	NULL
to	NULL
repress	NULL
GATA-3	NULL
if	NULL
exposure	NULL
occurred	NULL
during	NULL
this	NULL
period	NULL
.	NULL

Discussion	NULL
This	NULL
study	NULL
makes	NULL
several	NULL
novel	NULL
observations	NULL
.	NULL

First	NULL
,	NULL
GATA-3	NULL
acquires	NULL
a	NULL
Th2-specific	NULL
expression	NULL
not	NULL
simply	NULL
from	NULL
being	NULL
induced	NULL
by	NULL
IL-4	NULL
but	NULL
from	NULL
being	NULL
actively	NULL
repressed	NULL
by	NULL
IL-12	NULL
.	NULL

This	NULL
repression	NULL
of	NULL
GATA-3	NULL
mRNA	NULL
by	NULL
IL-12	NULL
involves	NULL
Stat4	NULL
.	NULL

Next	NULL
,	NULL
maintenance	NULL
of	NULL
GATA-3	NULL
expression	NULL
in	NULL
developing	NULL
T	NULL
cells	NULL
strongly	NULL
inhibits	NULL
IL-12-induced	NULL
Thi	NULL
development	NULL
,	NULL
not	NULL
simply	NULL
as	NULL
an	NULL
indirect	NULL
effect	NULL
of	NULL
augmenting	NULL
IL-4	NULL
production	NULL
but	NULL
rather	NULL
by	NULL
a	NULL
cell-autonomous	NULL
mechanism	NULL
occurring	NULL
independently	NULL
of	NULL
IL-4	NULL
.	NULL

However	NULL
,	NULL
introduction	NULL
of	NULL
GATA-3	NULL
into	NULL
a	NULL
differentiated	NULL
Th1	NULL
cell	NULL
does	NULL
not	NULL
inhibit	NULL
IFNy	NULL
production	NULL
,	NULL
and	NULL
GATA-3	NULL
does	NULL
not	NULL
directly	NULL
repress	NULL
the	NULL
IFNy	NULL
promoter	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
inhibition	NULL
by	NULL
GATA-3	NULL
of	NULL
IL-12-induced	NULL
Th1	NULL
development	NULL
is	NULL
limited	NULL
to	NULL
the	NULL
first	NULL
week	NULL
of	NULL
primary	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

We	NULL
observe	NULL
that	NULL
GATA-3	NULL
represses	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
expression	NULL
,	NULL
thereby	NULL
preventing	NULL
IL-12	NULL
signaling	NULL
during	NULL
an	NULL
early	NULL
developmental	NULL
window	NULL
and	NULL
blocking	NULL
Th1	NULL
development	NULL
.	NULL

This	NULL
mechanism	NULL
explains	NULL
the	NULL
previously	NULL
described	NULL
extinction	NULL
of	NULL
IL-12R	NULL
B2	NULL
mRNA	NULL
during	NULL
Th2	NULL
development	NULL
.	NULL

Recently	NULL
,	NULL
several	NULL
studies	NULL
have	NULL
analyzed	NULL
the	NULL
transcriptional	NULL
basis	NULL
for	NULL
Th	NULL
subset-specific	NULL
expression	NULL
of	NULL
various	NULL
cytokine	NULL
genes	NULL
.	NULL

The	NULL
transcription	NULL
factors	NULL
c-Maf	NULL
(	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
GATA-3	NULL
(	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
were	NULL
both	NULL
identified	NULL
as	NULL
Th2-specific	NULL
cytokines	NULL
,	NULL
with	NULL
c-Maf	NULL
being	NULL
shown	NULL
to	NULL
interact	NULL
directly	NULL
with	NULL
the	NULL
IL-4	NULL
proximal	NULL
promoter	NULL
and	NULL
having	NULL
actions	NULL
relatively	NULL
restricted	NULL
to	NULL
the	NULL
IL-4	NULL
but	NULL
not	NULL
the	NULL
IL-5	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GATA-3	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
a	NULL
Th2-specific	NULL
factor	NULL
that	NULL
may	NULL
act	NULL
on	NULL
other	NULL
cytokine	NULL
genes	NULL
,	NULL
particularly	NULL
IL-5	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

GATA	NULL
family	NULL
transcription	NULL
factors	NULL
regulate	NULL
many	NULL
lineage	NULL
and	NULL
cell-specific	NULL
processes	NULL
.	NULL

GATA-1	NULL
and	NULL
GATA-2	NULL
regulate	NULL
development	NULL
of	NULL
the	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
(	NULL
Weiss	NULL
and	NULL
Orkin	NULL
,	NULL
1995	NULL
;	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Maeno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Melotti	NULL
and	NULL
Calabretta	NULL
,	NULL
1996	NULL
;	NULL
Takahashi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

GATA-3	NULL
appears	NULL
to	NULL
play	NULL
roles	NULL
in	NULL
nervous	NULL
system	NULL
and	NULL
fetal	NULL
hemato-poetic	NULL
development	NULL
(	NULL
Pandolfi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
early	NULL
thymocyte	NULL
development	NULL
(	NULL
Hattori	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Ting	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

GATA-3	NULL
is	NULL
the	NULL
only	NULL
GATA	NULL
factor	NULL
expressed	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
its	NULL
regulation	NULL
is	NULL
complex	NULL
(	NULL
Lieuw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

T	NULL
cell-specific	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
were	NULL
identified	NULL
as	NULL
far	NULL
as	NULL
10.7	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
of	NULL
GATA-3	NULL
,	NULL
but	NULL
the	NULL
functional	NULL
role	NULL
in	NULL
directing	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
verified	NULL
(	NULL
Lieuw	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
Th2-specific	NULL
T	NULL
cell	NULL
expression	NULL
of	NULL
GATA-3	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

This	NULL
report	NULL
suggests	NULL
that	NULL
GATA-3	NULL
expression	NULL
is	NULL
augmented	NULL
by	NULL
IL-4	NULL
via	NULL
Stat6	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
but	NULL
that	NULL
full	NULL
Tha	NULL
specificity	NULL
involves	NULL
a	NULL
repression	NULL
in	NULL
Th1	NULL
cells	NULL
that	NULL
requires	NULL
IL-12	NULL
and	NULL
Statd4	NULL
to	NULL
become	NULL
complete	NULL
(	NULL
Figures	NULL
1A	NULL
and	NULL
1B	NULL
)	NULL
.	NULL

One	NULL
surprising	NULL
result	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
that	NULL
GATA-3	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
IL-4	NULL
production	NULL
as	NULL
previously	NULL
suggested	NULL
(	NULL
Zheng	NULL
and	NULL
Flavell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
GATA-3	NULL
continuously	NULL
after	NULL
activation	NULL
of	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
even	NULL
under	NULL
Th1-inducing	NULL
conditions	NULL
,	NULL
led	NULL
to	NULL
augmentation	NULL
of	NULL
IL-4	NULL
.	NULL

However	NULL
,	NULL
reexpression	NULL
of	NULL
GATA-3	NULL
in	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
developed	NULL
in	NULL
Th1-inducing	NULL
conditions	NULL
for	NULL
8	NULL
days	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
detectable	NULL
IL-4	NULL
production	NULL
,	NULL
despite	NULL
clear	NULL
demonstration	NULL
of	NULL
GATA-3	NULL
protein	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
GATA-3	NULL
augmentation	NULL
of	NULL
IL-4	NULL
expression	NULL
may	NULL
involve	NULL
processes	NULL
that	NULL
are	NULL
temporally	NULL
restricted	NULL
or	NULL
require	NULL
cooperation	NULL
with	NULL
unidentified	NULL
factors	NULL
.	NULL

This	NULL
report	NULL
also	NULL
suggests	NULL
that	NULL
GATA-3	NULL
inhibits	NULL
Th1	NULL
development	NULL
through	NULL
a	NULL
repression	NULL
of	NULL
IL-12	NULL
signaling	NULL
that	NULL
is	NULL
IL-4-independent	NULL
.	NULL

While	NULL
GATA	NULL
factors	NULL
typically	NULL
are	NULL
thought	NULL
of	NULL
as	NULL
positive	NULL
regulators	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
this	NULL
is	NULL
not	NULL
always	NULL
the	NULL
case	NULL
.	NULL

The	NULL
pannier	NULL
(	NULL
pnr	NULL
)	NULL
gene	NULL
,	NULL
a	NULL
Drosophila	NULL
melanogaster	NULL
protein	NULL
belonging	NULL
to	NULL
the	NULL
GATA	NULL
family	NULL
,	NULL
influences	NULL
expression	NULL
of	NULL
the	NULL
achaete	NULL
(	NULL
ac	NULL
)	NULL
and	NULL
scute	NULL
(	NULL
sc	NULL
)	NULL
genes	NULL
(	NULL
Ramain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Haenlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
and	NULL
may	NULL
act	NULL
either	NULL
as	NULL
a	NULL
repressor	NULL
or	NULL
activator	NULL
depending	NULL
on	NULL
association	NULL
with	NULL
other	NULL
factors	NULL
such	NULL
as	NULL
extramacrochaetae	NULL
(	NULL
eme	NULL
)	NULL
(	NULL
Heitzler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

During	NULL
the	NULL
first	NULL
week	NULL
after	NULL
primary	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
IL-12-induced	NULL
Stat4	NULL
activation	NULL
participates	NULL
in	NULL
the	NULL
Thi	NULL
developmental	NULL
program	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Kaplan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Thierfelder	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
GATA-3	NULL
and	NULL
IL-12	NULL
signaling	NULL
exert	NULL
mutually	NULL
antagonistic	NULL
effects	NULL
on	NULL
each	NULL
other	NULL
,	NULL
with	NULL
GATA-3	NULL
repressing	NULL
IL-12RB2	NULL
expression	NULL
and	NULL
IL-12	NULL
signaling	NULL
repressing	NULL
GATA-3	NULL
expression	NULL
.	NULL

This	NULL
mechanism	NULL
could	NULL
explain	NULL
why	NULL
maintenance	NULL
of	NULL
GATA-3	NULL
during	NULL
the	NULL
first	NULL
7	NULL
days	NULL
of	NULL
Th1	NULL
induction	NULL
leads	NULL
to	NULL
a	NULL
significant	NULL
inhibition	NULL
of	NULL
IFNy	NULL
production	NULL
.	NULL

Reexpression	NULL
of	NULL
GATA-3	NULL
on	NULL
day	NULL
8	NULL
by	NULL
retrovirus	NULL
fails	NULL
to	NULL
reduce	NULL
IFNy	NULL
production	NULL
,	NULL
since	NULL
the	NULL
Stat4-dependent	NULL
program	NULL
that	NULL
allows	NULL
TCR-driven	NULL
IFNy	NULL
production	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
has	NULL
already	NULL
taken	NULL
place	NULL
.	NULL

Mutual	NULL
repressive	NULL
antagonism	NULL
between	NULL
paired	NULL
signaling	NULL
pathways	NULL
is	NULL
a	NULL
common	NULL
theme	NULL
in	NULL
lineage	NULL
specification	NULL
and	NULL
development	NULL
.	NULL

In	NULL
Drosophila	NULL
development	NULL
,	NULL
neuroec-toderm	NULL
determination	NULL
is	NULL
influenced	NULL
by	NULL
Notch	NULL
signaling	NULL
,	NULL
where	NULL
a	NULL
lateral	NULL
inhibition	NULL
mechanism	NULL
of	NULL
ligand	NULL
expression	NULL
and	NULL
fate	NULL
determination	NULL
may	NULL
stabilize	NULL
local	NULL
divergence	NULL
of	NULL
cell	NULL
differentiation	NULL
(	NULL
Artavanis-Tsakonas	NULL
and	NULL
Simpson	NULL
,	NULL
1991	NULL
;	NULL
Greenwald	NULL
and	NULL
Rubin	NULL
,	NULL
1992	NULL
;	NULL
Kopan	NULL
and	NULL
Cagan	NULL
,	NULL
1997	NULL
;	NULL
Crowe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
;	NULL
Rooke	NULL
and	NULL
Xu	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

Similar	NULL
mechanisms	NULL
potentially	NULL
involving	NULL
Notch	NULL
participate	NULL
in	NULL
y8/	NULL
«	NULL
f	NULL
and	NULL
CD4*/CD8	NULL
*	NULL
T	NULL
cell	NULL
lineage	NULL
divergences	NULL
(	NULL
Robey	NULL
and	NULL
Fowlkes	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

Another	NULL
example	NULL
of	NULL
repression	NULL
in	NULL
lineage	NULL
specification	NULL
appears	NULL
in	NULL
the	NULL
molecular	NULL
regulation	NULL
of	NULL
the	NULL
and	NULL
CD8*	NULL
coreceptor	NULL
genes	NULL
during	NULL
thymocyte	NULL
maturation	NULL
from	NULL
double-positive	NULL
precursors	NULL
(	NULL
Sawada	NULL
and	NULL
Littman	NULL
,	NULL
1991	NULL
;	NULL
Elimeier	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
Th1/Th2	NULL
development	NULL
,	NULL
mutually	NULL
antagonistic	NULL
signals	NULL
are	NULL
seen	NULL
at	NULL
several	NULL
levels	NULL
.	NULL

At	NULL
the	NULL
gross	NULL
cytokine	NULL
level	NULL
,	NULL
IL-12	NULL
and	NULL
IL-4	NULL
exert	NULL
mutually	NULL
antagonistic	NULL
effects	NULL
on	NULL
their	NULL
production	NULL
.	NULL

A	NULL
squelching	NULL
mechanism	NULL
between	NULL
distinct	NULL
STAT	NULL
factors	NULL
could	NULL
underlie	NULL
cross	NULL
inhibition	NULL
,	NULL
but	NULL
the	NULL
immediate	NULL
target	NULL
genes	NULL
influenced	NULL
by	NULL
Stat4	NULL
and	NULL
Stat6	NULL
are	NULL
not	NULL
clearly	NULL
identified	NULL
at	NULL
present	NULL
.	NULL

This	NULL
study	NULL
provides	NULL
evidence	NULL
that	NULL
GATA-3	NULL
and	NULL
the	NULL
IL-12	NULL
receptor	NULL
pathway	NULL
exert	NULL
mutual	NULL
antagonistic	NULL
effects	NULL
on	NULL
each	NULL
oth-er	NULL
's	NULL
expression	NULL
,	NULL
representing	NULL
an	NULL
unstable	NULL
situation	NULL
that	NULL
diverges	NULL
to	NULL
the	NULL
stable	NULL
dominance	NULL
of	NULL
one	NULL
and	NULL
extinction	NULL
of	NULL
the	NULL
other	NULL
,	NULL
generating	NULL
either	NULL
a	NULL
Thi	NULL
or	NULL
Th2	NULL
cytokine	NULL
profile	NULL
.	NULL

IL-4-Independent	NULL
Th1	NULL
Repression	NULL
by	NULL
GATA-3	NULL
753	NULL
Experimental	NULL
Procedures	NULL
Mice	NULL
,	NULL
Cytokines	NULL
,	NULL
and	NULL
Antibodies	NULL
Stat1-	NULL
,	NULL
Stat4-	NULL
,	NULL
and	NULL
Stat6-deficient	NULL
mice	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
R.	NULL
D.	NULL
Schreiber	NULL
(	NULL
Meraz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
Dr.	NULL
J.	NULL
N.	NULL
Ihle	NULL
(	NULL
Thierfelder	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
and	NULL
Dr.	NULL
M.	NULL
J.	NULL
Grusby	NULL
(	NULL
Kaplan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
IL4	NULL
(	NULL
-/-	NULL
)	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
were	NULL
from	NULL
Dr.	NULL
O.	NULL
Kanagawa	NULL
.	NULL

Stati-	NULL
and	NULL
Statd-deficient	NULL
mice	NULL
were	NULL
backcrossed	NULL
three	NULL
times	NULL
to	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
(	NULL
Murphy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
before	NULL
interbreeding	NULL
to	NULL
generate	NULL
Stat1	NULL
(	NULL
-/-	NULL
)	NULL
and	NULL
Stat4	NULL
(	NULL
-/-	NULL
)	NULL
H-2	NULL
``	NULL
DO11.10	NULL
TCR-transgenic	NULL
experimental	NULL
animals	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-2	NULL
was	NULL
provided	NULL
by	NULL
Takeda	NULL
(	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
murine	NULL
fL-12	NULL
by	NULL
Genetics	NULL
Institute	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
murine	NULL
rIFNy	NULL
by	NULL
Genentech	NULL
(	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
murine	NULL
rIL-18	NULL
from	NULL
Research	NULL
Diagnostics	NULL
,	NULL
Inc.	NULL
(	NULL
Flanders	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Murine	NULL
rIL-4	NULL
was	NULL
generated	NULL
from	NULL
transfected	NULL
P815	NULL
mastocytoma	NULL
cells	NULL
as	NULL
high-titer	NULL
culture	NULL
supernatant	NULL
.	NULL

Monoclonal	NULL
anti-mIFNy	NULL
(	NULL
H22	NULL
)	NULL
was	NULL
from	NULL
Dr.	NULL
R.	NULL
D.	NULL
Schreiber	NULL
;	NULL
monoclonal	NULL
anti-lL-4	NULL
(	NULL
11B11	NULL
)	NULL
(	NULL
Ohara	NULL
and	NULL
Paul	NULL
,	NULL
1985	NULL
)	NULL
,	NULL
anti-lL-12	NULL
(	NULL
Tosh	NULL
)	NULL
(	NULL
Tripp	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
and	NULL
anti-CD3	NULL
(	NULL
500A2	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
affinity	NULL
chromatography	NULL
under	NULL
endotoxin-free	NULL
conditions	NULL
from	NULL
culture	NULL
supernatant	NULL
.	NULL

500A2	NULL
cell	NULL
line	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
J.	NULL
P.	NULL
Allison	NULL
(	NULL
Berkeley	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

T	NULL
Cell	NULL
Activation	NULL
and	NULL
Phenotype	NULL
Differentiation	NULL
Splenocytes	NULL
from	NULL
TCR-transgenic	NULL
mice	NULL
were	NULL
purified	NULL
on	NULL
a	NULL
density	NULL
gradient	NULL
(	NULL
Histopaque-1119	NULL
,	NULL
Sigma	NULL
)	NULL
and	NULL
activated	NULL
by	NULL
chick	NULL
oval-bumin	NULL
peptide	NULL
323-339	NULL
(	NULL
OVA	NULL
)	NULL
at	NULL
3	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
IMDM	NULL
media	NULL
.	NULL

Concanavalin	NULL
A	NULL
(	NULL
1	NULL
mg/m	NULL
!	NULL
)	NULL

was	NULL
used	NULL
to	NULL
activate	NULL
T	NULL
cells	NULL
from	NULL
Stat6	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
(	NULL
3	NULL
X	NULL
106	NULL
cells	NULL
/ml	NULL
)	NULL
.	NULL

IL-12	NULL
(	NULL
10	NULL
U/ml	NULL
)	NULL
and	NULL
anti-IL-4	NULL
(	NULL
11811	NULL
,	NULL
10	NULL
pg/ml	NULL
)	NULL
were	NULL
added	NULL
for	NULL
Thi	NULL
development	NULL
,	NULL
and	NULL
IL-4	NULL
(	NULL
100	NULL
U/m	NULL
!	NULL

1	NULL
)	NULL
and	NULL
anti-IL-12	NULL
(	NULL
Tosh	NULL
,	NULL
3	NULL
g/m	NULL
!	NULL
)	NULL

for	NULL
Th2	NULL
development	NULL
.	NULL

For	NULL
retroviral	NULL
infection	NULL
experiments	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
harvested	NULL
on	NULL
day	NULL
7	NULL
after	NULL
primary	NULL
activation	NULL
and	NULL
purified	NULL
by	NULL
cell	NULL
sorting	NULL
for	NULL
GFP	NULL
expression	NULL
.	NULL

For	NULL
passage	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
harvested	NULL
7	NULL
days	NULL
after	NULL
the	NULL
last	NULL
activation	NULL
by	NULL
OVA	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
stimulated	NULL
with	NULL
OVA	NULL
peptides	NULL
(	NULL
0.3	NULL
M	NULL
)	NULL
at	NULL
1.25	NULL
X	NULL
10°	NULL
cell/ml	NULL
with	NULL
irradiated	NULL
BALB/c	NULL
splenocytes	NULL
(	NULL
2000	NULL
rads	NULL
,	NULL
2.5	NULL
x	NULL
10°	NULL
cells	NULL
/ml	NULL
)	NULL
with	NULL
addition	NULL
of	NULL
the	NULL
indicated	NULL
cytokines	NULL
.	NULL

For	NULL
ELISA	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
after	NULL
48	NULL
hr	NULL
and	NULL
measured	NULL
as	NULL
described	NULL
(	NULL
Hsieh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19933	NULL
)	NULL
.	NULL

The	NULL
Th1	NULL
clone	NULL
3F6	NULL
derived	NULL
from	NULL
DO11.10	NULL
TCR	NULL
transgenic	NULL
T	NULL
cells	NULL
(	NULL
Jacobson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
was	NULL
maintained	NULL
by	NULL
biweekly	NULL
antigen	NULL
stimulation	NULL
as	NULL
above	NULL
.	NULL

For	NULL
anti-CD3	NULL
stimulation	NULL
,	NULL
5	NULL
g/ml	NULL
anti-CD3	NULL
antibody	NULL
(	NULL
500A2	NULL
)	NULL
in	NULL
PBS	NULL
was	NULL
coated	NULL
overnight	NULL
onto	NULL
48-well	NULL
plates	NULL
(	NULL
1	NULL
ml/well	NULL
)	NULL
at	NULL
4°C	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
T	NULL
cells	NULL
applied	NULL
(	NULL
2.5	NULL
x	NULL
10°	NULL
cells	NULL
/m	NULL
!	NULL
)	NULL

with	NULL
cytokines	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Retroviral	NULL
Constructs	NULL
and	NULL
Retroviral	NULL
Transfection	NULL
To	NULL
generate	NULL
the	NULL
GFP-RV	NULL
vector	NULL
,	NULL
a	NULL
600	NULL
bp	NULL
EcoRl-Ncol	NULL
fragment	NULL
comprising	NULL
the	NULL
encephalomyocarditis	NULL
virus	NULL
internal	NULL
ribosomal	NULL
entry	NULL
sequence	NULL
(	NULL
IRES	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
pCITE-1	NULL
(	NULL
Novagen	NULL
)	NULL
and	NULL
a	NULL
700	NULL
bp	NULL
Ncol-EcoRl	NULL
humanized	NULL
GFP	NULL
allele	NULL
hGFP-S65T	NULL
(	NULL
Clonetech	NULL
)	NULL
containing	NULL
an	NULL
additional	NULL
solubility	NULL
point	NULL
mutation	NULL
(	NULL
163	NULL
V	NULL
>	NULL
T	NULL
)	NULL
were	NULL
ligated	NULL
into	NULL
the	NULL
EcoRl	NULL
site	NULL
of	NULL
pBluescript	NULL
II	NULL
SK	NULL
(	NULL
-	NULL
)	NULL
(	NULL
Stratagene	NULL
)	NULL
in	NULL
a	NULL
trimolecu-lar	NULL
ligation	NULL
.	NULL

A	NULL
1.3	NULL
kb	NULL
Xhol-BamHI	NULL
from	NULL
this	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
1.3	NULL
kb	NULL
pgk-neomycin	NULL
cassette	NULL
MSCV2.2	NULL
retroviral	NULL
vector	NULL
(	NULL
Hawley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

GATA-3	NULL
cDNA	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
R/M	NULL
GATA-3	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
J	NULL
.	NULL

D	NULL
.	NULL

Engel	NULL
!	NULL
)	NULL

(	NULL
Ko	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
as	NULL
template	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
were	NULL
GAATTCGTCGACGCTCTGCCTCTCTAACCCAT	NULL
and	NULL
GAATTCGTCGACGGACATGGAGGTGACTGCGGA	NULL
.	NULL

The	NULL
Salil	NULL
digested	NULL
PCR	NULL
product	NULL
was	NULL
ligated	NULL
to	NULL
Xhol	NULL
digested	NULL
GFP-RV	NULL
vector	NULL
.	NULL

This	NULL
GATA-3-RV	NULL
plasmid	NULL
was	NULL
confirmed	NULL
by	NULL
sequencing	NULL
.	NULL

The	NULL
KRR	NULL
mutation	NULL
of	NULL
GATA-3	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
was	NULL
made	NULL
using	NULL
the	NULL
primers	NULL
CCCCTTATCAAGCCCGCGGCAGCGCTGTCGGCAGCAAGG	NULL
and	NULL
CCTTGCTGCCGACAGCGCTGCCGCGGGCTTGATAAGGGG	NULL
,	NULL
which	NULL
was	NULL
confirmed	NULL
by	NULL
complete	NULL
sequencing	NULL
.	NULL

Phoenix-Eco	NULL
packaging	NULL
cell	NULL
line	NULL
(	NULL
gift	NULL
of	NULL
Dr.	NULL
G.	NULL
Nolan	NULL
,	NULL
Stanford	NULL
CA	NULL
)	NULL
were	NULL
transfected	NULL
according	NULL
to	NULL
Dr.	NULL
Nolan	NULL
's	NULL
protocol	NULL
.	NULL

Primary	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
as	NULL
described	NULL
above	NULL
and	NULL
infected	NULL
after	NULL
24	NULL
hr	NULL
using	NULL
a	NULL
1:2	NULL
volume	NULL
of	NULL
viral	NULL
supernatant	NULL
and	NULL
polybrene	NULL
(	NULL
Sigma	NULL
,	NULL
MO	NULL
)	NULL
at	NULL
6	NULL
g/ml	NULL
,	NULL
centrifuged	NULL
at	NULL
1800	NULL
rom	NULL
for	NULL
45	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
48	NULL
hr	NULL
before	NULL
being	NULL
supplied	NULL
with	NULL
fresh	NULL
media	NULL
and	NULL
expanded	NULL
until	NULL
day	NULL
7	NULL
after	NULL
primary	NULL
activation	NULL
.	NULL

RNA	NULL
,	NULL
Northern	NULL
Blots	NULL
,	NULL
and	NULL
RNase	NULL
Protection	NULL
Assay	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
RNeasy	NULL
kit	NULL
(	NULL
QIAGEN	NULL
)	NULL
,	NULL
10	NULL
pg/lane	NULL
separated	NULL
by	NULL
electrophoresis	NULL
and	NULL
transferred	NULL
to	NULL
Zeta	NULL
Probe	NULL
membrane	NULL
(	NULL
BioRAD	NULL
)	NULL
.	NULL

10°	NULL
cpm/ml	NULL
probe	NULL
was	NULL
used	NULL
for	NULL
Northern	NULL
hybridization	NULL
.	NULL

The	NULL
GATA-3	NULL
probe	NULL
was	NULL
1.5	NULL
kb	NULL
cDNA	NULL
above	NULL
.	NULL

IL-12RB2	NULL
chain	NULL
probe	NULL
,	NULL
GAPDH	NULL
,	NULL
or	NULL
HPPRT	NULL
probes	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
mCK-1	NULL
and	NULL
mCK-3	NULL
multi-probe	NULL
template	NULL
sets	NULL
(	NULL
PharMingen	NULL
)	NULL
were	NULL
used	NULL
for	NULL
multiple	NULL
cytokine	NULL
gene	NULL
RNase	NULL
protection	NULL
assays	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
2	NULL
ug/sample	NULL
)	NULL
was	NULL
applied	NULL
and	NULL
RNase	NULL
protection	NULL
was	NULL
performed	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
method	NULL
(	NULL
PharMingen	NULL
)	NULL
.	NULL

Reporter	NULL
Construct	NULL
and	NULL
Luciferase	NULL
Assay	NULL
A	NULL
3.5	NULL
kb	NULL
murine	NULL
IFNy	NULL
promoter	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
H.	NULL
Fox	NULL
(	NULL
Scripps	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
Fox	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

5	NULL
'	NULL
oligonucleotides	NULL
with	NULL
Sall	NULL
tails	NULL
and	NULL
3	NULL
'	NULL
oligonucleotides	NULL
with	NULL
BamHI	NULL
tails	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
a	NULL
series	NULL
of	NULL
5'-truncations	NULL
of	NULL
the	NULL
IFNy	NULL
promoter	NULL
by	NULL
PCR	NULL
and	NULL
cloned	NULL
into	NULL
Sall/Bgill	NULL
digested	NULL
pBS-Luc	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
CMV-promoter	NULL
was	NULL
used	NULL
to	NULL
express	NULL
Renilla	NULL
luciferase	NULL
(	NULL
Promega	NULL
)	NULL
for	NULL
normalization	NULL
of	NULL
transfection	NULL
.	NULL

EL-4	NULL
cells	NULL
(	NULL
10	NULL
'	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
g	NULL
of	NULL
IFNy	NULL
reporter	NULL
construct	NULL
,	NULL
10	NULL
mp	NULL
GFP-RV	NULL
or	NULL
GATA-3-RV	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
CMV-Renilla	NULL
luciferase	NULL
construct	NULL
in	NULL
1.2	NULL
ml	NULL
RPMI	NULL
,	NULL
electropor-ated	NULL
(	NULL
960	NULL
uF	NULL
,	NULL
280	NULL
V	NULL
)	NULL
as	NULL
described	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

At	NULL
12	NULL
to	NULL
14	NULL
hr	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
activated	NULL
by	NULL
50	NULL
ng/ml	NULL
PMA	NULL
and	NULL
1	NULL
M	NULL
ionomycin	NULL
as	NULL
indicated	NULL
for	NULL
4	NULL
hr	NULL
and	NULL
luciferase	NULL
measure	NULL
as	NULL
described	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
T	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
stimulated	NULL
as	NULL
indicated	NULL
were	NULL
lysed	NULL
in	NULL
30	NULL
wl	NULL
cell	NULL
lysis	NULL
buffer	NULL
(	NULL
5	NULL
%	NULL
SDS	NULL
,	NULL
0.5	NULL
M	NULL
Tris	NULL
[	NULL
pH	NULL
6.8	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
and	NULL
10	NULL
g	NULL
Leupeptin	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
centrifuged	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
,	NULL
supernatants	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

Blots	NULL
were	NULL
probed	NULL
with	NULL
murine	NULL
monoclonal	NULL
anti-GATA-3	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
1:3000	NULL
)	NULL
and	NULL
developed	NULL
as	NULL
described	NULL
(	NULL
Guler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
Jacobson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

3	NULL
ug	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
with	NULL
P-labeled	NULL
m67	NULL
or	NULL
Ea	NULL
probe	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cpm	NULL
)	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
Szabo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
with	NULL
1	NULL
ug	NULL
poly-dIdC	NULL
for	NULL
30	NULL
min	NULL
before	NULL
addition	NULL
of	NULL
gel	NULL
loading	NULL
buffer	NULL
and	NULL
electrophoresis	NULL
at	NULL
room	NULL
temperature	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Intracellular	NULL
IFNy	NULL
Staining	NULL
and	NULL
FACS	NULL
Analysis	NULL
Intracellular	NULL
staining	NULL
was	NULL
based	NULL
on	NULL
the	NULL
method	NULL
of	NULL
Assenmacher	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Primary	NULL
DO11.10	NULL
T	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
GFP-RV	NULL
or	NULL
GATA-3	NULL
retrovirus	NULL
as	NULL
described	NULL
above	NULL
.	NULL

On	NULL
day	NULL
7	NULL
after	NULL
primary	NULL
activation	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
for	NULL
2	NULL
hr	NULL
and	NULL
10	NULL
g/m	NULL
!	NULL

Brefeldin	NULL
A	NULL
(	NULL
Epicenter	NULL
Technology	NULL
)	NULL
added	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
hr	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
suspended	NULL
in	NULL
200	NULL
ul	NULL
PBS	NULL
,	NULL
fixed	NULL
for	NULL
20	NULL
min	NULL
with	NULL
4	NULL
%	NULL
paraformalde-hyde	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
in	NULL
2	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
and	NULL
suspended	NULL
in	NULL
PBS	NULL
,	NULL
2	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
saponin	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
10	NULL
min	NULL
.	NULL

PE-conjugated	NULL
anti-murine	NULL
IFNy	NULL
and	NULL
Cy-Chrome-conjugated	NULL
anti-murine-CD4	NULL
(	NULL
PharMingen	NULL
)	NULL
were	NULL
added	NULL
for	NULL
30	NULL
min	NULL
,	NULL
the	NULL
cells	NULL
washed	NULL
twice	NULL
in	NULL
saponin/FCS/PBS	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
FACSCalibur	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Gates	NULL
for	NULL
GFP	NULL
(	NULL
FL1	NULL
)	NULL
positive	NULL
cells	NULL
were	NULL
determined	NULL
using	NULL
nontransfected	NULL
controls	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
J.	NULL
D.	NULL
Engel	NULL
(	NULL
Evanston	NULL
,	NULL
IL	NULL
)	NULL
for	NULL
the	NULL
R/M	NULL
GATA-3	NULL
plasmid	NULL
,	NULL
A.	NULL
Winoto	NULL
(	NULL
Berkeley	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
human	NULL
version	NULL
of	NULL
the	NULL
KRR	NULL
GATA-3	NULL
mutant	NULL
,	NULL
and	NULL
Debbie	NULL
Wyman	NULL
for	NULL
excellent	NULL
cell	NULL
sorting	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
Al31238	NULL
and	NULL
AIDK39676	NULL
.	NULL

K.	NULL
M.	NULL
M.	NULL
is	NULL
an	NULL
Associate	NULL
Investigator	NULL
of	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

Received	NULL
September	NULL
2	NULL
,	NULL
1998	NULL
;	NULL
revised	NULL
October	NULL
22	NULL
,	NULL
1998	NULL
.	NULL

References	NULL
Abbas	NULL
,	NULL
AK	NULL
.	NULL

,	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
and	NULL
Sher	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Functional	NULL
diversity	NULL
of	NULL
T	NULL
helper	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
383	NULL
,	NULL
787-793	NULL
.	NULL

Immunity	NULL
754	NULL
Artavanis-Tsakonas	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Simpson	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Choosing	NULL
a	NULL
cell	NULL
fate	NULL
:	NULL
a	NULL
view	NULL
from	NULL
the	NULL
Notch	NULL
locus	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

7	NULL
,	NULL
403-408	NULL
.	NULL

Assenmacher	NULL
,	NULL
M.	NULL
,	NULL
Schmitz	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Radbruch	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Flow	NULL
cyto-metric	NULL
determination	NULL
of	NULL
cytokines	NULL
in	NULL
activated	NULL
murine	NULL
T	NULL
helper	NULL
lym-phocytes	NULL
:	NULL
expression	NULL
of	NULL
interleukin-10	NULL
in	NULL
interferon-gamma	NULL
and	NULL
in	NULL
interleukin-4-expressing	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24	NULL
,	NULL
1097-1101	NULL
.	NULL

Bach	NULL
,	NULL
E.A	NULL
.	NULL

,	NULL
Aguet	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Schreiber	NULL
,	NULL
R.D	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
IFN	NULL
gamma	NULL
receptor	NULL
:	NULL
a	NULL
paradigm	NULL
for	NULL
cytokine	NULL
receptor	NULL
signaling	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15	NULL
,	NULL
563-591	NULL
.	NULL

Bacon	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
Petricoin	NULL
,	NULL
E.F.	NULL
,	NULL
III	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.R.	NULL
,	NULL
Rees	NULL
,	NULL
R.C	NULL
.	NULL

,	NULL
Larner	NULL
,	NULL
A.C.	NULL
,	NULL
Johnston	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
and	NULL
O'Shea	NULL
,	NULL
J.J.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Interleukin	NULL
12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STAT4	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
7307-7311	NULL
.	NULL

Cippitelli	NULL
,	NULL
M.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
Viggiano	NULL
,	NULL
V.	NULL
,	NULL
Ye	NULL
,	NULL
J.	NULL
,	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Birrer	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
H.A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Negative	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interferon-gamma	NULL
promoter	NULL
by	NULL
glucocorticoids	NULL
and	NULL
dominant	NULL
negative	NULL
mutants	NULL
of	NULL
c-Jun	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
12548-12556	NULL
.	NULL

Crowe	NULL
,	NULL
R.	NULL
,	NULL
Henrique	NULL
,	NULL
D.	NULL
,	NULL
Ish-Horowicz	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Niswander	NULL
,	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

A	NULL
new	NULL
role	NULL
for	NULL
Notch	NULL
and	NULL
Delta	NULL
in	NULL
cell	NULL
fate	NULL
decisions	NULL
:	NULL
patterning	NULL
the	NULL
feather	NULL
array	NULL
.	NULL

Development	NULL
125	NULL
,	NULL
767-775.	NULL
de	NULL
Saint-Vis	NULL
,	NULL
B.	NULL
,	NULL
Fugier-Vivier	NULL
,	NULL
I.	NULL
,	NULL
Massacrier	NULL
,	NULL
C.	NULL
,	NULL
Gaillard	NULL
,	NULL
C.	NULL
,	NULL
Van-bervliet	NULL
,	NULL
Ait-	NULL
Yahia	NULL
,	NULL
S.	NULL
,	NULL
Banchereau	NULL
,	NULL
J.	NULL
,	NULL
Liu	NULL
,	NULL
Y.J	NULL
.	NULL

,	NULL
Lebecque	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Caux	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
cytokine	NULL
profile	NULL
expressed	NULL
by	NULL
human	NULL
dendritic	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
cell	NULL
subtype	NULL
and	NULL
mode	NULL
of	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
1666-1676	NULL
.	NULL

Elimeier	NULL
,	NULL
W.	NULL
,	NULL
Sunshine	NULL
,	NULL
M.J.	NULL
,	NULL
Losos	NULL
,	NULL
K.	NULL
,	NULL
Hatam	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Littman	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

An	NULL
enhancer	NULL
that	NULL
directs	NULL
lineage-specific	NULL
expression	NULL
of	NULL
CD8	NULL
in	NULL
positively	NULL
selected	NULL
thymocytes	NULL
and	NULL
mature	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
7	NULL
,	NULL
537-547	NULL
.	NULL

Fox	NULL
,	NULL
H.S	NULL
.	NULL

,	NULL
Bond	NULL
,	NULL
B.L	NULL
.	NULL

,	NULL
and	NULL
Parslow	NULL
,	NULL
T.G	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Estrogen	NULL
regulates	NULL
the	NULL
IFNy	NULL
promoter	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
4362-4367	NULL
.	NULL

Greenwald	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Rubin	NULL
,	NULL
G.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Making	NULL
a	NULL
difference	NULL
:	NULL
the	NULL
role	NULL
of	NULL
cell-cell	NULL
interactions	NULL
in	NULL
establishing	NULL
separate	NULL
identities	NULL
for	NULL
equivalent	NULL
cells	NULL
.	NULL

Cell	NULL
68	NULL
,	NULL
271-281	NULL
.	NULL

Guler	NULL
,	NULL
ML	NULL
.	NULL

,	NULL
Jacobson	NULL
,	NULL
N.G	NULL
.	NULL

,	NULL
Gubler	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
genetic	NULL
background	NULL
determines	NULL
maintenance	NULL
of	NULL
IL-12	NULL
signaling	NULL
:	NULL
effects	NULL
on	NULL
BALB/c	NULL
and	NULL
B10.D2	NULL
T	NULL
helper	NULL
cell	NULL
type	NULL
1	NULL
phenotype	NULL
development	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159	NULL
,	NULL
1767-1774	NULL
.	NULL

Haenlin	NULL
,	NULL
M.	NULL
,	NULL
Cubadda	NULL
,	NULL
Y.	NULL
,	NULL
Blondeau	NULL
,	NULL
F.	NULL
,	NULL
Heitzler	NULL
,	NULL
P.	NULL
,	NULL
Lutz	NULL
,	NULL
Y.	NULL
,	NULL
Simpson	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Ramain	NULL
,	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
pannier	NULL
is	NULL
regulated	NULL
negatively	NULL
by	NULL
heterodimerization	NULL
of	NULL
the	NULL
GATA	NULL
DNA-bind-ing	NULL
domain	NULL
with	NULL
a	NULL
cofactor	NULL
encoded	NULL
by	NULL
the	NULL
u-shaped	NULL
gene	NULL
of	NULL
Drosophila	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
3096-3108	NULL
.	NULL

Hattori	NULL
,	NULL
N.	NULL
,	NULL
Kawamoto	NULL
,	NULL
H.	NULL
,	NULL
Fujimoto	NULL
,	NULL
S.	NULL
,	NULL
Kuno	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Katsura	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Involvement	NULL
of	NULL
transcription	NULL
factors	NULL
TCF-1	NULL
and	NULL
GATA-3	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
earliest	NULL
step	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
,	NULL
1137-1147	NULL
.	NULL

Hawley	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
Lieu	NULL
,	NULL
F.H	NULL
.	NULL

,	NULL
Fong	NULL
,	NULL
A.Z	NULL
.	NULL

,	NULL
and	NULL
Hawley	NULL
,	NULL
T.S	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Versatile	NULL
retroviral	NULL
vectors	NULL
for	NULL
potential	NULL
use	NULL
in	NULL
gene	NULL
therapy	NULL
.	NULL

Gene	NULL
Ther	NULL
.	NULL

1	NULL
,	NULL
136-138	NULL
.	NULL

Heitzler	NULL
,	NULL
P.	NULL
,	NULL
Haenlin	NULL
,	NULL
M.	NULL
,	NULL
Ramain	NULL
,	NULL
P.	NULL
,	NULL
Calleja	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Simpson	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

A	NULL
genetic	NULL
analysis	NULL
of	NULL
pannier	NULL
,	NULL
a	NULL
gene	NULL
necessary	NULL
for	NULL
viability	NULL
of	NULL
dorsal	NULL
tissues	NULL
and	NULL
bristle	NULL
positioning	NULL
in	NULL
Drosophila	NULL
.	NULL

Genetics	NULL
143	NULL
,	NULL
1271-1286	NULL
.	NULL

Ho	NULL
,	NULL
1.C	NULL
.	NULL

,	NULL
Hodge	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Rooney	NULL
,	NULL
J.W	NULL
.	NULL

,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.H	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
proto-oncogene	NULL
c-matf	NULL
is	NULL
responsible	NULL
for	NULL
tissue-specific	NULL
expression	NULL
of	NULL
interleukin-4	NULL
.	NULL

Cell	NULL
85	NULL
,	NULL
973-983	NULL
.	NULL

Hsieh	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Macatonia	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
O'Garra	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
199323	NULL
)	NULL
.	NULL

Pathogen-induced	NULL
Thi	NULL
phenotype	NULL
development	NULL
in	NULL
CD4+	NULL
alpha	NULL
beta-TCR	NULL
transgenic	NULL
T	NULL
cells	NULL
is	NULL
macrophage	NULL
dependent	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

5	NULL
,	NULL
371-382	NULL
.	NULL

Hsieh	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Macatonia	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Tripp	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Wolf	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
O'Garra	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1993b	NULL
)	NULL
.	NULL

Development	NULL
of	NULL
TH1	NULL
CD4+	NULL
T	NULL
cells	NULL
through	NULL
IL-12	NULL
produced	NULL
by	NULL
Listeria-induced	NULL
macrophages	NULL
.	NULL

Science	NULL
260	NULL
,	NULL
547-549	NULL
.	NULL

Jacobson	NULL
,	NULL
N.G	NULL
.	NULL

,	NULL
Szabo	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Weber-Nordt	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Schreiber	NULL
,	NULL
R.D	NULL
.	NULL

,	NULL
Darnell	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
Jr.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Interleukin	NULL
12	NULL
signaling	NULL
in	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
cells	NULL
involves	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
3	NULL
and	NULL
Statd4	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
1755-1762	NULL
.	NULL

Kaplan	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
Sun	NULL
,	NULL
Y.L	NULL
.	NULL

,	NULL
Hoey	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Grusby	NULL
,	NULL
M.J.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Impaired	NULL
IL-12	NULL
responses	NULL
and	NULL
enhanced	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
in	NULL
Stat4-deficient	NULL
mice	NULL
.	NULL

Nature	NULL
382	NULL
,	NULL
174-177	NULL
.	NULL

Ko	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.W	NULL
.	NULL

,	NULL
George	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Ting	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Murine	NULL
and	NULL
human	NULL
T-lymphocyte	NULL
GATA-3	NULL
factors	NULL
mediate	NULL
transcription	NULL
through	NULL
a	NULL
cis-regulatory	NULL
element	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
delta	NULL
gene	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2778-2784	NULL
.	NULL

Kopan	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Cagan	NULL
,	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Notch	NULL
on	NULL
the	NULL
cutting	NULL
edge	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

13	NULL
,	NULL
465-467	NULL
.	NULL

Lee	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
O'Garra	NULL
,	NULL
A.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
cis-regulatory	NULL
elements	NULL
and	NULL
nuclear	NULL
factors	NULL
conferring	NULL
Th2-specific	NULL
expression	NULL
of	NULL
the	NULL
IL-5	NULL
gene	NULL
:	NULL
a	NULL
role	NULL
for	NULL
a	NULL
GATA-binding	NULL
protein	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
2343-2352	NULL
.	NULL

Lieuw	NULL
,	NULL
K.H	NULL
.	NULL

,	NULL
Li	NULL
,	NULL
G.	NULL
,	NULL
Zhou	NULL
,	NULL
Y.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.D	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Temporal	NULL
and	NULL
spatial	NULL
control	NULL
of	NULL
murine	NULL
GATA-3	NULL
transcription	NULL
by	NULL
promoter-proximal	NULL
regulatory	NULL
elements	NULL
.	NULL

Dev	NULL
.	NULL

Biol	NULL
.	NULL

188	NULL
,	NULL
1-16	NULL
.	NULL

Macatonia	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Hsieh	NULL
,	NULL
C.-S.	NULL
,	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
and	NULL
O'Garra	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Dendritic	NULL
cells	NULL
and	NULL
macrophages	NULL
are	NULL
required	NULL
for	NULL
Th1	NULL
development	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
from	NULL
alpha	NULL
beta	NULL
TCR	NULL
transgenic	NULL
mice	NULL
:	NULL
IL-12	NULL
substitution	NULL
for	NULL
macrophages	NULL
to	NULL
stimulate	NULL
IFNy	NULL
production	NULL
is	NULL
IFNy-depen-dent	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

5	NULL
,	NULL
1119-1128	NULL
.	NULL

Macatonia	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Hosken	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
Litton	NULL
,	NULL
M.	NULL
,	NULL
Vieira	NULL
,	NULL
P.	NULL
,	NULL
Hsieh	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Culpepper	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Wysocka	NULL
,	NULL
M.	NULL
,	NULL
Trinchieri	NULL
,	NULL
G.	NULL
,	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
and	NULL
O'Garra	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Dendritic	NULL
cells	NULL
produce	NULL
IL-12	NULL
and	NULL
direct	NULL
the	NULL
development	NULL
of	NULL
Thi	NULL
cells	NULL
from	NULL
naive	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
5071-5079	NULL
.	NULL

Maeno	NULL
,	NULL
M.	NULL
,	NULL
Mead	NULL
,	NULL
P.E	NULL
.	NULL

,	NULL
Kelley	NULL
,	NULL
C.	NULL
,	NULL
Xu	NULL
,	NULL
R.H.	NULL
,	NULL
Kung	NULL
,	NULL
H.F.	NULL
,	NULL
Suzuki	NULL
,	NULL
A.	NULL
,	NULL
Ueno	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Zon	NULL
,	NULL
L.1	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
BMP-4	NULL
and	NULL
GATA-2	NULL
in	NULL
the	NULL
induction	NULL
and	NULL
differentiation	NULL
of	NULL
hematopoietic	NULL
mesoderm	NULL
in	NULL
Xen-opus	NULL
laevis	NULL
.	NULL

Blood	NULL
88	NULL
,	NULL
1965-1972	NULL
.	NULL

Manetti	NULL
,	NULL
R.	NULL
,	NULL
Parronchi	NULL
,	NULL
P.	NULL
,	NULL
Giudizi	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Piccinni	NULL
,	NULL
M.-P.	NULL
,	NULL
Maggi	NULL
,	NULL
E.	NULL
,	NULL
Trinchieri	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Romagnani	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Natural	NULL
killer	NULL
cell	NULL
stimulatory	NULL
factor	NULL
(	NULL
interleukin	NULL
12	NULL
[	NULL
IL-12	NULL
]	NULL
)	NULL
induces	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Th1	NULL
}	NULL
specific	NULL
immune	NULL
responses	NULL
and	NULL
inhibits	NULL
the	NULL
development	NULL
of	NULL
IL-4-producing	NULL
Th	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177	NULL
,	NULL
1199-1204	NULL
.	NULL

Melotti	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factors	NULL
c-myb	NULL
and	NULL
GATA-2	NULL
act	NULL
independently	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
normal	NULL
hematopoiesis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
5313-5318	NULL
.	NULL

Meraz	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
White	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Sheehan	NULL
,	NULL
K.C	NULL
.	NULL

,	NULL
Bach	NULL
,	NULL
E.A	NULL
.	NULL

,	NULL
Rodig	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Dighe	NULL
,	NULL
A.S.	NULL
,	NULL
Kaplan	NULL
,	NULL
D.H.	NULL
,	NULL
Riley	NULL
,	NULL
J.K.	NULL
,	NULL
Greenlund	NULL
,	NULL
A.C.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
Stat1	NULL
gene	NULL
in	NULL
mice	NULL
reveals	NULL
unexpected	NULL
physiologic	NULL
specificity	NULL
in	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
path-way	NULL
.	NULL

Cell	NULL
84	NULL
,	NULL
431-442	NULL
.	NULL

Murphy	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Heimberger	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
and	NULL
Loh	NULL
,	NULL
D.Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Induction	NULL
by	NULL
antigen	NULL
of	NULL
intrathymic	NULL
apoptosis	NULL
of	NULL
CD4+	NULL
CD8+	NULL
TCR-lo	NULL
thymocytes	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
250	NULL
,	NULL
1720-1723	NULL
.	NULL

Ohara	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.E	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
.	NULL

Production	NULL
of	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
and	NULL
molecular	NULL
characterization	NULL
of	NULL
B-cell	NULL
stimulatory	NULL
fac-tor-1	NULL
.	NULL

Nature	NULL
3175	NULL
,	NULL
333-336	NULL
.	NULL

Okamura	NULL
,	NULL
H.	NULL
,	NULL
Tsutsi	NULL
,	NULL
H.	NULL
,	NULL
Komatsu	NULL
,	NULL
T.	NULL
,	NULL
Yutsudo	NULL
,	NULL
M.	NULL
,	NULL
Hakura	NULL
,	NULL
A.	NULL
,	NULL
Tani-moto	NULL
,	NULL
T.	NULL
,	NULL
Torigoe	NULL
,	NULL
K.	NULL
,	NULL
Okura	NULL
,	NULL
T.	NULL
,	NULL
Nukada	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hattori	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
new	NULL
cytokine	NULL
that	NULL
induces	NULL
IFNy	NULL
production	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
378	NULL
,	NULL
88-91	NULL
.	NULL

Pandolfi	NULL
,	NULL
P.P	NULL
.	NULL

,	NULL
Roth	NULL
,	NULL
ME	NULL
.	NULL

,	NULL
Karis	NULL
,	NULL
A.	NULL
,	NULL
Leonard	NULL
,	NULL
M.W	NULL
.	NULL

,	NULL
Dzierzak	NULL
,	NULL
E.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.G.	NULL
,	NULL
Engel	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
and	NULL
Lindenbaum	NULL
,	NULL
M.H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
GATA3	NULL
gene	NULL
causes	NULL
severe	NULL
abnormalities	NULL
in	NULL
the	NULL
nervous	NULL
system	NULL
and	NULL
in	NULL
fetal	NULL
liver	NULL
haematopoiesis	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

77	NULL
,	NULL
40-44	NULL
.	NULL

Penix	NULL
,	NULL
L.	NULL
,	NULL
Weaver	NULL
,	NULL
W.M	NULL
.	NULL

,	NULL
Pang	NULL
,	NULL
Y.	NULL
,	NULL
Young	NULL
,	NULL
H.A	NULL
.	NULL

,	NULL
and	NULL
Wilson	NULL
,	NULL
C.B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Two	NULL
essential	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
interferon	NULL
gamma	NULL
promoter	NULL
confer	NULL
activation	NULL
specific	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1483-1496	NULL
.	NULL

Penix	NULL
,	NULL
L.A.	NULL
,	NULL
Sweetser	NULL
,	NULL
M.T	NULL
.	NULL

,	NULL
Weaver	NULL
,	NULL
W.M	NULL
.	NULL

,	NULL
Hoeffler	NULL
,	NULL
J.P.	NULL
,	NULL
Kerppola	NULL
,	NULL
T.K	NULL
.	NULL

,	NULL
and	NULL
Wilson	NULL
,	NULL
C.B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
proximal	NULL
regulatory	NULL
element	NULL
of	NULL
the	NULL
interferon-gamma	NULL
promoter	NULL
mediates	NULL
selective	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
31964-31972	NULL
.	NULL

Ramain	NULL
,	NULL
P.	NULL
,	NULL
Heitzler	NULL
,	NULL
P.	NULL
,	NULL
Haenlin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Simpson	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

pannier	NULL
,	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
achaete	NULL
and	NULL
scute	NULL
in	NULL
Drosophila	NULL
,	NULL
encodes	NULL
a	NULL
zinc	NULL
finger	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
vertebrate	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Development	NULL
119	NULL
,	NULL
1277-1291	NULL
.	NULL

IL-4-Independent	NULL
Th1	NULL
Repression	NULL
by	NULL
GATA-3	NULL
755	NULL
Robey	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Fowlkes	NULL
,	NULL
B.J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
alpha	NULL
beta	NULL
versus	NULL
gamma	NULL
delta	NULL
T-cell	NULL
lineage	NULL
choice	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

10	NULL
,	NULL
181-187	NULL
.	NULL

Robinson	NULL
,	NULL
D.	NULL
,	NULL
Shibuya	NULL
,	NULL
K.	NULL
,	NULL
Mui	NULL
,	NULL
A.	NULL
,	NULL
Zonin	NULL
,	NULL
F.	NULL
,	NULL
Murphy	NULL
,	NULL
E.	NULL
,	NULL
Sana	NULL
,	NULL
T.	NULL
,	NULL
Hartley	NULL
,	NULL
S.B	NULL
.	NULL

,	NULL
Menon	NULL
,	NULL
S.	NULL
,	NULL
Kastelein	NULL
,	NULL
R.	NULL
,	NULL
Bazan	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
O'Garra	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

IGIF	NULL
does	NULL
not	NULL
drive	NULL
Thi	NULL
development	NULL
but	NULL
synergizes	NULL
with	NULL
IL-12	NULL
for	NULL
interferon-y	NULL
production	NULL
and	NULL
activates	NULL
IRAK	NULL
and	NULL
NFkB	NULL
.	NULL

Immunity	NULL
7	NULL
,	NULL
571-581	NULL
.	NULL

Rooke	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
and	NULL
Xu	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
signals	NULL
between	NULL
interacting	NULL
cells	NULL
for	NULL
establishing	NULL
neural	NULL
fate	NULL
.	NULL

Bioessays	NULL
20	NULL
,	NULL
209-214	NULL
.	NULL

Sawada	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Littman	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
T-cell-specific	NULL
enhancer	NULL
adjacent	NULL
to	NULL
the	NULL
murine	NULL
CD4	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
5506-5515	NULL
.	NULL

Sica	NULL
,	NULL
A.	NULL
,	NULL
Dorman	NULL
,	NULL
L.	NULL
,	NULL
Viggiano	NULL
,	NULL
V.	NULL
,	NULL
Cippitelli	NULL
,	NULL
M.	NULL
,	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
H.A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Interaction	NULL
of	NULL
NF-kappaB	NULL
and	NULL
NFAT	NULL
with	NULL
the	NULL
interferon-gamma	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
30412-30420	NULL
.	NULL

Smith	NULL
,	NULL
V.M	NULL
.	NULL

,	NULL
Lee	NULL
,	NULL
P.P	NULL
.	NULL

,	NULL
Szychowski	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Winoto	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

GATA-3	NULL
dominant	NULL
negative	NULL
mutant	NULL
.	NULL

Functional	NULL
redundancy	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
alpha	NULL
and	NULL
beta	NULL
enhancers	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
1515-1520	NULL
.	NULL

Szabo	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Gold	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
Murphy	NULL
,	NULL
T.L	NULL
.	NULL

,	NULL
and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
roles	NULL
for	NULL
NF-Y	NULL
and	NULL
NF-ATc	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
4793-4805	NULL
.	NULL

Szabo	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Jacobson	NULL
,	NULL
N.G	NULL
.	NULL

,	NULL
Dighe	NULL
,	NULL
A.S.	NULL
,	NULL
Gubler	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Developmental	NULL
commitment	NULL
to	NULL
the	NULL
Th2	NULL
lineage	NULL
by	NULL
extinction	NULL
of	NULL
IL-	NULL
12	NULL
signaling	NULL
.	NULL

Immunity	NULL
2	NULL
,	NULL
665-675	NULL
.	NULL

Szabo	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Dighe	NULL
,	NULL
A.S.	NULL
,	NULL
Gubler	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Murphy	NULL
,	NULL
K.M	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-12R	NULL
beta	NULL
2	NULL
subunit	NULL
expression	NULL
in	NULL
developing	NULL
T	NULL
helper	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185	NULL
,	NULL
817-824	NULL
.	NULL

Takahashi	NULL
,	NULL
S.	NULL
,	NULL
Onodera	NULL
,	NULL
K.	NULL
,	NULL
Motohashi	NULL
,	NULL
H.	NULL
,	NULL
Suwabe	NULL
,	NULL
N.	NULL
,	NULL
Hayashi	NULL
,	NULL
N.	NULL
,	NULL
Yanai	NULL
,	NULL
N.	NULL
,	NULL
Nabesima	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Arrest	NULL
in	NULL
primitive	NULL
erythroid	NULL
cell	NULL
development	NULL
caused	NULL
by	NULL
promoter-specific	NULL
disruption	NULL
of	NULL
the	NULL
GATA-1	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
12611-12615	NULL
.	NULL

Thierfelder	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
van	NULL
Deursen	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
Tripp	NULL
,	NULL
R.A.	NULL
,	NULL
Sarawar	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Carson	NULL
,	NULL
R.T.	NULL
,	NULL
Sangster	NULL
,	NULL
M.Y	NULL
.	NULL

,	NULL
Vignali	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
Doherty	NULL
,	NULL
P.C	NULL
.	NULL

,	NULL
Grosveld	NULL
,	NULL
G.C	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Requirement	NULL
for	NULL
Statd4	NULL
in	NULL
interleu-kin-12-mediated	NULL
responses	NULL
of	NULL
natural	NULL
killer	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
382	NULL
,	NULL
171-174	NULL
.	NULL

Ting	NULL
,	NULL
C.N	NULL
.	NULL

,	NULL
Olson	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Barton	NULL
,	NULL
K.P	NULL
.	NULL

,	NULL
and	NULL
Leiden	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
required	NULL
for	NULL
development	NULL
of	NULL
the	NULL
T-cell	NULL
lineage	NULL
.	NULL

Nature	NULL
384	NULL
,	NULL
474-478	NULL
.	NULL

Tripp	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Gately	NULL
,	NULL
MK	NULL
.	NULL

,	NULL
Hakimi	NULL
,	NULL
J.	NULL
,	NULL
Ling	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Unanue	NULL
,	NULL
E.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Neutralization	NULL
of	NULL
IL-12	NULL
decreases	NULL
resistance	NULL
to	NULL
Listeria	NULL
in	NULL
SCID	NULL
and	NULL
C.	NULL
B-17	NULL
mice	NULL
.	NULL

Reversal	NULL
by	NULL
IFNy	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
1883-1887	NULL
.	NULL

Weiss	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

GATA	NULL
transcription	NULL
factors	NULL
:	NULL
key	NULL
regulators	NULL
of	NULL
hematopoiesis	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

23	NULL
,	NULL
99-107	NULL
.	NULL

Wu	NULL
,	NULL
Y.	NULL
,	NULL
Fraizer	NULL
,	NULL
G.C	NULL
.	NULL

,	NULL
and	NULL
Saunders	NULL
,	NULL
G.F.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

GATA-1	NULL
transacti-vates	NULL
the	NULL
WT1	NULL
hematopoietic	NULL
specific	NULL
enhancer	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
5944-5949	NULL
.	NULL

Xu	NULL
,	NULL
X.	NULL
,	NULL
Sun	NULL
,	NULL
Y.L	NULL
.	NULL

,	NULL
and	NULL
Hoey	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Cooperative	NULL
DNA	NULL
binding	NULL
and	NULL
sequence-selective	NULL
recognition	NULL
conferred	NULL
by	NULL
the	NULL
STAT	NULL
amino-terminal	NULL
domain	NULL
.	NULL

Science	NULL
273	NULL
,	NULL
794-797	NULL
.	NULL

Ye	NULL
,	NULL
J.	NULL
,	NULL
Cippitelli	NULL
,	NULL
M.	NULL
,	NULL
Dorman	NULL
,	NULL
L.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.R.	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
H.A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
factor	NULL
YY1	NULL
suppresses	NULL
the	NULL
human	NULL
gamma	NULL
interferon	NULL
promoter	NULL
through	NULL
two	NULL
mechanisms	NULL
:	NULL
inhibition	NULL
of	NULL
AP1	NULL
binding	NULL
and	NULL
activation	NULL
of	NULL
a	NULL
silencer	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
4744-4753	NULL
.	NULL

Young	NULL
,	NULL
H.A	NULL
.	NULL

,	NULL
and	NULL
Hardy	NULL
,	NULL
K.J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Role	NULL
of	NULL
interferon-gamma	NULL
in	NULL
immune	NULL
cell	NULL
regulation	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

58	NULL
,	NULL
373-381	NULL
.	NULL

Zhang	NULL
,	NULL
D.H.	NULL
,	NULL
Cohn	NULL
,	NULL
L.	NULL
,	NULL
Ray	NULL
,	NULL
P.	NULL
,	NULL
Bottomly	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ray	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
murine	NULL
Thi	NULL
and	NULL
Th2	NULL
cells	NULL
and	NULL
controls	NULL
Th2-specific	NULL
expression	NULL
of	NULL
the	NULL
in-terleukin-5	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
21597-21603	NULL
.	NULL

Zheng	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.A.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
GATA-3	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
Th2	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
89	NULL
,	NULL
587-596	NULL
.	NULL

